{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:02:53Z","timestamp":1793336573940,"version":"4.5.0"},"reference-count":1268,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.hrthm.2017.10.036","type":"journal-article","created":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T14:15:55Z","timestamp":1509372955000},"page":"e73-e189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":321,"title":["2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death"],"prefix":"10.1016","volume":"15","author":[{"given":"Sana M.","family":"Al-Khatib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Callans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne B.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.","family":"Deal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timm","family":"Dickfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Field","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg C.","family":"Fonarow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Gillis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Hammill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Hlatky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Joglar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Neal","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel D.","family":"Matlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Myerburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2017.10.036_bib1","series-title":"Clinical Practice Guidelines We Can Trust","year":"2011"},{"key":"10.1016\/j.hrthm.2017.10.036_bib2","series-title":"Finding What Works in Health Care: Standards for Systematic Reviews","year":"2011"},{"key":"10.1016\/j.hrthm.2017.10.036_bib3","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.jacc.2014.03.016","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines","volume":"63","author":"Anderson","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib4","unstructured":"ACCF\/AHA Task Force on Practice Guidelines. Methodology Manual and Policies From the ACCF\/AHA\u00a0Task Force on Practice Guidelines. American College of Cardiology and American Heart Association, 2010. Available at: http:\/\/assets.cardiosource.com\/Methodology_Manual_for_ACC_AHA_Writing_Committees.pdf and http:\/\/professional.heart.org\/idc\/groups\/ahamah-public\/@wcm\/@sop\/documents\/downloadable\/ucm_319826.pdf. Accessed October 1,\u00a02017."},{"key":"10.1016\/j.hrthm.2017.10.036_bib5","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.jacc.2014.07.012","volume":"64","author":"Arnett","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib6","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.jacc.2015.09.001","article-title":"Further evolution of the ACC\/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"67","author":"Halperin","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib7","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jacc.2014.06.001","article-title":"The evolution and future of ACC\/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Jacobs","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jacc.2012.09.025","article-title":"ACCF\/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"Jacobs","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib9","author":"Kusumoto","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib10","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.jacc.2014.03.016","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines","volume":"63","author":"Anderson","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib11","unstructured":"World Health Organization. CHOosing Interventions that are Cost Effective (WHO-CHOICE): cost-effectiveness thresholds. Available at: http:\/\/www.who.int\/choice\/en\/. Accessed March 26,\u00a02013."},{"key":"10.1016\/j.hrthm.2017.10.036_bib12","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1016\/j.jacc.2006.07.010","volume":"48","author":"Zipes","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib13","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","volume":"51","author":"Epstein","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib14","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","volume":"58","author":"Gersh","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib15","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2006.09.020","volume":"48","author":"Buxton","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib16","first-page":"1","article-title":"2015 HRS\/EHRA\/APHRS\/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing","volume":"32","author":"Wilkoff","year":"2016","journal-title":"J\u00a0Arrhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib17","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1161\/CIR.0000000000000394","article-title":"Wearable cardioverter-defibrillator therapy for the prevention of sudden cardiac death: a science advisory from the American Heart Association","volume":"133","author":"Piccini","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib18","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.jacc.2017.03.003","article-title":"2017 ACC\/AHA\/HRS guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"70","author":"Shen","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib19","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib20","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jacc.2016.05.011","volume":"68","author":"Yancy","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib21","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"70","author":"Nishimura","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib23","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.jacc.2014.02.536","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib24","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.jacc.2015.08.856","article-title":"2015 ACC\/AHA\/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"67","author":"Page","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib25","first-page":"108","volume":"17","author":"Priori","year":"2016","journal-title":"G\u00a0Ital Cardiol (Rome)"},{"key":"10.1016\/j.hrthm.2017.10.036_bib26","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIR.0000000000000144","volume":"132","author":"Perkins","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib27","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib28","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib29","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1016\/j.jacc.2014.02.606","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk","volume":"63","author":"Andrus","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib30","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O\u2019Gara","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib31","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Steg","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib32","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jacc.2012.07.009","article-title":"2012 ACCF\/AHA\/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"60","author":"Tracy","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib33","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.jacc.2011.08.009","volume":"58","author":"Hillis","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib34","first-page":"E266","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"82","author":"Levine","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2017.10.036_bib35","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.jacc.2011.10.824","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation","volume":"58","author":"Smith","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib36","series-title":"Committee on the Treatment of Cardiac Arrest: Current Status and Future Directions: Strategies to improve cardiac arrest survival: a time to act","year":"2015"},{"key":"10.1016\/j.hrthm.2017.10.036_bib37","first-page":"e334","volume":"132","author":"Link","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib38","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1016\/j.hrthm.2014.07.024","article-title":"EHRA\/HRS\/APHRS expert consensus on ventricular arrhythmias","volume":"11","author":"Pedersen","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib39","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/j.hrthm.2014.05.009","article-title":"PACES\/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS)","volume":"11","author":"Khairy","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib40","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jacc.2014.04.008","article-title":"HRS\/ACC\/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials","volume":"64","author":"Kusumoto","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib41","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib42","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib43","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/CIRCULATIONAHA.111.023846","article-title":"Sudden cardiac death caused by coronary heart disease","volume":"125","author":"Myerburg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib44","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2006.09.020","article-title":"ACC\/AHA\/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Data Standards","volume":"48","author":"Buxton","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"375","author":"Sapp","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib46","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib47","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1161\/01.CIR.25.6.947","article-title":"Electrocardiographic findings in 122,043 individuals","volume":"25","author":"Hiss","year":"1962","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib48","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0002-9149(77)80094-5","article-title":"Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease","volume":"39","author":"Brodsky","year":"1977","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib49","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.amjcard.2006.06.061","article-title":"Usefulness of ventricular premature complexes to predict coronary heart disease events and mortality (from the Atherosclerosis Risk In Communities cohort)","volume":"98","author":"Massing","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib50","doi-asserted-by":"crossref","first-page":"e002519","DOI":"10.1161\/JAHA.112.002519","article-title":"Premature cardiac contractions and risk of incident ischemic stroke","volume":"1","author":"Ofoma","year":"2012","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2017.10.036_bib51","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.amjcard.2013.05.065","article-title":"Meta-analysis of ventricular premature complexes and their relation to cardiac mortality in general populations","volume":"112","author":"Ataklte","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib52","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijcard.2014.11.110","article-title":"Long-term outcome of multiform premature ventricular complexes in structurally normal heart","volume":"180","author":"Lin","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib53","doi-asserted-by":"crossref","first-page":"e0160181","DOI":"10.1371\/journal.pone.0160181","article-title":"Long-term outcome of non-sustained ventricular tachycardia in structurally normal hearts","volume":"11","author":"Lin","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.hrthm.2017.10.036_bib54","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/01.CIR.64.2.297","article-title":"Ventricular premature complexes and sudden death after myocardial infarction","volume":"64","author":"Ruberman","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib55","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1056\/NEJM197710062971404","article-title":"Ventricular premature beats and mortality after myocardial infarction","volume":"297","author":"Ruberman","year":"1977","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib56","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM199207233270403","article-title":"Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. The Cardiac Arrhythmia Suppression Trial II Investigators","volume":"327","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib57","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib58","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/01.CIR.84.5.1977","article-title":"Quinidine-related mortality in the short-to-medium-term treatment of ventricular arrhythmias. A meta-analysis","volume":"84","author":"Morganroth","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(96)02149-6","article-title":"Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol","volume":"348","author":"Waldo","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib60","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCEP.113.000805","article-title":"Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract: prospective randomized study","volume":"7","author":"Ling","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib61","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJM200009213431201","article-title":"Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations","volume":"343","author":"Jouven","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib62","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa022353","article-title":"Frequent ventricular ectopy after exercise as a predictor of death","volume":"348","author":"Frolkis","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib63","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0735-1097(02)01977-0","article-title":"Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes","volume":"40","author":"Biffi","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib64","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0195-668X(03)00282-3","article-title":"High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias: role of an electrophysiologic study in risk stratification","volume":"24","author":"Heidb\u00fcchel","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib65","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1542-474X.2007.00204.x","article-title":"Frequent premature ventricular complexes originating from the right ventricular outflow tract are associated with left ventricular dysfunction","volume":"13","author":"Kanei","year":"2008","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib66","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCEP.111.963348","article-title":"Premature ventricular contraction-induced cardiomyopathy: a treatable condition","volume":"5","author":"Lee","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib67","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1540-8167.2005.50040.x","article-title":"The \u201cshort-coupled\u201d variant of right ventricular outflow ventricular tachycardia: a not-so-benign form of benign ventricular tachycardia?","volume":"16","author":"Viskin","year":"2005","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib68","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2005.05.077","article-title":"Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract","volume":"46","author":"Noda","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib69","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/CIRCINTERVENTIONS.109.913665","article-title":"Immediate percutaneous coronary intervention is associated with better survival after out-of-hospital cardiac arrest: insights from the PROCAT (Parisian Region Out of hospital Cardiac ArresT) registry","volume":"3","author":"Dumas","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2017.10.036_bib70","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/MCA.0b013e32834022fa","article-title":"Incidence of, predictors for, and mortality associated with malignant ventricular arrhythmias in non-ST elevation myocardial infarction patients","volume":"21","author":"Gupta","year":"2010","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.hrthm.2017.10.036_bib71","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.amjcard.2009.07.037","article-title":"Prevalence and significance of accelerated idioventricular rhythm in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"104","author":"Terkelsen","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib72","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.CIR.0000022692.49934.E3","article-title":"Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes","volume":"106","author":"Al-Khatib","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib73","doi-asserted-by":"crossref","first-page":"e001399","DOI":"10.1161\/JAHA.114.001399","article-title":"Incidence and risk factors of ventricular fibrillation before primary angioplasty in patients with first ST-elevation myocardial infarction: a nationwide study in Denmark","volume":"4","author":"Jabbari","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2017.10.036_bib74","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1001\/jama.2009.600","article-title":"Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention","volume":"301","author":"Mehta","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib75","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/0002-9149(89)90174-4","article-title":"One-year prognosis of primary ventricular fibrillation complicating acute myocardial infarction. The GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell\u2019Infarto miocardico) investigators","volume":"63","author":"Volpi","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib76","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/01.RES.49.1.255","article-title":"Canine ventricular arrhythmias in the late myocardial infarction period. 8. Epicardial mapping of reentrant circuits","volume":"49","author":"El-Sherif","year":"1981","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2017.10.036_bib77","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/europace\/eur245","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"13","author":"Ackerman","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib78","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/CIRCGENETICS.111.961102","article-title":"Mortality of inherited arrhythmia syndromes: insight into their natural history","volume":"5","author":"Nannenberg","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib79","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0140-6736(02)07807-8","article-title":"Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation","volume":"359","author":"Ha\u00efssaguerre","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib80","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/01.CIR.0000027564.55739.B1","article-title":"Mapping and ablation of idiopathic ventricular fibrillation","volume":"106","author":"Ha\u00efssaguerre","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib81","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1161\/CIRCULATIONAHA.110.959734","article-title":"Risk stratification for arrhythmic sudden cardiac death: identifying the roadblocks","volume":"123","author":"Goldberger","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib82","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/CIRCULATIONAHA.110.976092","article-title":"Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop","volume":"122","author":"Fishman","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib83","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1046\/j.1540-8167.2001.00369.x","article-title":"Sudden cardiac death: exploring the limits of our knowledge","volume":"12","author":"Myerburg","year":"2001","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib84","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jacc.2010.09.064","article-title":"Systematic review of the incidence of sudden cardiac death in the United States","volume":"57","author":"Kong","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib85","first-page":"e38","article-title":"Heart disease and stroke statistics\u20142016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib86","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics\u20142017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib87","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1097\/CCM.0b013e3182257459","article-title":"Incidence of treated cardiac arrest in hospitalized patients in the United States","volume":"39","author":"Merchant","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib88","series-title":"Committee on the Treatment of Cardiac Arrest: Current Status and Future Directions: Strategies to improve cardiac arrest survival: a time to act","year":"2015"},{"key":"10.1016\/j.hrthm.2017.10.036_bib89","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1161\/CIRCULATIONAHA.116.025818","article-title":"Improving care of out-of-hospital cardiac arrest: next steps","volume":"134","author":"Jollis","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib90","unstructured":"Daya MR, Schmicker R, May SH, et\u00a0al. Current burden of cardiac arrest in the United States: report from the Resuscitation Outcomes Consortium. Paper commissioned by the Committee on the Treatment of Cardiac Arrest: Current Status and Future Directions.\u00a02015."},{"key":"10.1016\/j.hrthm.2017.10.036_bib91","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1161\/CIRCULATIONAHA.113.004490","article-title":"Pulseless electric activity: definition, causes, mechanisms, management, and research priorities for the next decade: report from a National Heart, Lung, and Blood Institute workshop","volume":"128","author":"Myerburg","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib92","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1001\/jamacardio.2017.0266","article-title":"Sudden cardiac arrest risk assessment: population science and the individual risk mandate","volume":"2","author":"Myerburg","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib93","doi-asserted-by":"crossref","first-page":"e002398","DOI":"10.1161\/JAHA.115.002398","article-title":"Lifetime risk for sudden cardiac death in the community","volume":"5","author":"Bogle","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2017.10.036_bib94","doi-asserted-by":"crossref","first-page":"e003723","DOI":"10.1161\/CIRCEP.115.003723","article-title":"Temporal trends in the clinical and pathological characteristics of victims of sudden cardiac death in the absence of previously identified heart disease","volume":"9","author":"Junttila","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib95","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.hrthm.2011.06.031","article-title":"Causes of nonischemic sudden cardiac death in the current era","volume":"8","author":"Hookana","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib96","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/CIRCULATIONAHA.114.010633","article-title":"Trends in short- and long-term survival among out-of-hospital cardiac arrest patients alive at hospital arrival","volume":"130","author":"Wong","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib97","doi-asserted-by":"crossref","first-page":"H2451","DOI":"10.1152\/ajpheart.00770.2011","article-title":"Mechanisms of ventricular arrhythmias: a dynamical systems-based perspective","volume":"302","author":"Cherry","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib98","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/CIRCRESAHA.111.300158","article-title":"Rotors and the dynamics of cardiac fibrillation","volume":"112","author":"Pandit","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2017.10.036_bib99","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00395-013-0336-2","article-title":"Electrical storm: recent pathophysiological insights and therapeutic consequences","volume":"108","author":"Tsuji","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib100","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1113\/JP270526","article-title":"Predicting drug-induced QT prolongation and torsades de pointes","volume":"594","author":"Roden","year":"2016","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib101","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-3-642-41588-3_7","article-title":"The role of late I Na in development of cardiac arrhythmias","volume":"221","author":"Antzelevitch","year":"2014","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib102","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrcardio.2015.121","article-title":"Mechanism, diagnosis, and treatment of outflow tract tachycardia","volume":"12","author":"Lerman","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib103","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/CIRCRESAHA.110.226845","article-title":"Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis","volume":"108","author":"Priori","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2017.10.036_bib104","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1540-8159.2011.03044.x","article-title":"Purkinje-related arrhythmias part I: monomorphic ventricular tachycardias","volume":"34","author":"Nogami","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrcardio.2015.193","article-title":"Ventricular arrhythmias and the His-Purkinje system","volume":"13","author":"Haissaguerre","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib106","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.hrthm.2008.11.005","article-title":"Mechanisms of VF maintenance: wandering wavelets, mother rotors, or foci","volume":"6","author":"Tabereaux","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib107","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/pace.12882","article-title":"Electrophysiologic scar substrate in relation to VT: noninvasive high-resolution mapping and risk assessment with ECGI","volume":"39","author":"Zhang","year":"2016","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib108","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.hrthm.2016.05.013","article-title":"Substrate modification or ventricular tachycardia induction, mapping, and ablation as the first step? A randomized study","volume":"13","author":"Fernandez-Armenta","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib109","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0735-1097(93)90724-F","article-title":"Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope","volume":"21","author":"Middlekauff","year":"1993","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib110","series-title":"Braunwald\u2019s Heart Disease: A Textbook of Cardiovascular Medicine","first-page":"821","article-title":"Cardiac arrest and sudden cardiac death - Chapter 39","author":"Myerburg","year":"2015"},{"key":"10.1016\/j.hrthm.2017.10.036_bib111","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.jacc.2017.03.003","article-title":"2017 ACC\/AHA\/HRS guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"70","author":"Shen","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib112","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJMoa012407","article-title":"Incidence and prognosis of syncope","volume":"347","author":"Soteriades","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib113","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2005.05.077","article-title":"Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract","volume":"46","author":"Noda","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib114","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1540-8167.2005.50040.x","article-title":"The \u201cshort-coupled\u201d variant of right ventricular outflow ventricular tachycardia: a not-so-benign form of benign ventricular tachycardia?","volume":"16","author":"Viskin","year":"2005","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib115","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1056\/NEJM199805073381907","article-title":"Evaluation of patients with palpitations","volume":"338","author":"Zimetbaum","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib116","unstructured":"Credible meds. Available at: http:\/\/www.crediblemeds.org. Accessed December 26,\u00a02016."},{"key":"10.1016\/j.hrthm.2017.10.036_bib117","unstructured":"Brugada drugs. Available at: http:\/\/www.brugadadrugs.org. Accessed October 6,\u00a02016."},{"key":"10.1016\/j.hrthm.2017.10.036_bib118","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.hrthm.2016.03.016","article-title":"Drug-induced Brugada syndrome: clinical characteristics and risk factors","volume":"13","author":"Konigstein","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib119","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/CIRCULATIONAHA.115.016291","article-title":"Arrhythmic mitral valve prolapse and sudden cardiac death","volume":"132","author":"Basso","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib120","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/jce.12914","article-title":"Bileaflet mitral valve prolapse and risk of ventricular dysrhythmias and death","volume":"27","author":"Nordhues","year":"2016","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib121","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jacc.2013.02.060","article-title":"Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic out-of-hospital cardiac arrest","volume":"62","author":"Sriram","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib122","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1056\/NEJMra000650","article-title":"Sudden death due to cardiac arrhythmias","volume":"345","author":"Huikuri","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib123","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1540-8167.2011.02185.x","article-title":"Sentinel symptoms in patients with unexplained cardiac arrest: from the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER)","volume":"23","author":"Krahn","year":"2012","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib124","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/europace\/eus154","article-title":"The relation between age, sex, comorbidity, and pharmacotherapy and the risk of syncope: a Danish nationwide study","volume":"14","author":"Ruwald","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib125","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1161\/01.CIR.83.5.1649","article-title":"A\u00a0new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex","volume":"83","author":"Brugada","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib126","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0002-9343(78)90176-6","article-title":"The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex","volume":"64","author":"Wellens","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib127","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/jama.1989.03420070063031","article-title":"Wide QRS tachycardia in the conscious adult. Ventricular tachycardia is the most frequent cause","volume":"261","author":"Steinman","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0002-9149(02)02428-1","article-title":"Functional and prognostic significance of exercise-induced ventricular arrhythmias in patients with suspected coronary artery disease","volume":"90","author":"Elhendy","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib129","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jama.279.2.153","article-title":"Prognostic significance of exercise-induced left bundle-branch block","volume":"279","author":"Grady","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib130","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.hrthm.2014.06.037","article-title":"Prognostic value of the electrocardiogram in patients with syncope: data from the group for syncope study in the emergency room (GESINUR)","volume":"11","author":"Perez-Rodon","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib131","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1067\/mhj.2002.121264","article-title":"Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure","volume":"143","author":"Baldasseroni","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib132","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jacc.2005.03.060","article-title":"QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators","volume":"46","author":"Buxton","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib133","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.amjmed.2005.08.028","article-title":"Prognostic significance of quantitative QRS duration","volume":"119","author":"Desai","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib134","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.hrthm.2008.02.013","article-title":"Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II)","volume":"5","author":"Dhar","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib135","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0735-1097(87)80162-6","article-title":"Bundle branch block in patients with chronic coronary artery disease: angiographic correlates and prognostic significance","volume":"10","author":"Freedman","year":"1987","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib136","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1067\/mhj.2002.122516","article-title":"QRS duration and mortality in patients with congestive heart failure","volume":"143","author":"Iuliano","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib137","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib138","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/01.CIR.0000139311.32278.32","article-title":"Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial","volume":"110","author":"Zimetbaum","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib139","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jacc.2008.08.077","article-title":"The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention","volume":"53","author":"Costantini","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib140","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jelectrocard.2013.08.004","article-title":"Prognostic value of average T-wave alternans and QT variability for cardiac events in MADIT-II patients","volume":"46","author":"Monasterio","year":"2013","journal-title":"J\u00a0Electrocardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib141","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.jacc.2008.08.018","volume":"52","author":"Chow","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib142","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ahj.2011.11.021","article-title":"Ability of microvolt T-wave alternans to modify risk assessment of ventricular tachyarrhythmic events: a meta-analysis","volume":"163","author":"Gupta","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib143","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1161\/01.CIR.0000143160.14610.53","article-title":"Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum","volume":"110","author":"Bloomfield","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib144","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.amjmed.2013.10.003","article-title":"Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring","volume":"127","author":"Barrett","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib145","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/europace\/eut411","article-title":"Comparison of the patient-activated event recording system vs. traditional 24 h Holter electrocardiography in individuals with paroxysmal palpitations or dizziness","volume":"16","author":"de Asmundis","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib146","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0002-9149(90)90591-N","article-title":"Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope","volume":"66","author":"Linzer","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib147","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.amjcard.2013.04.017","article-title":"Diagnostic utility of a novel leadless arrhythmia monitoring device","volume":"112","author":"Turakhia","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib148","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/CIRCULATIONAHA.109.902148","article-title":"Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study","volume":"122","author":"Bloch Thomsen","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib149","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/01.CIR.99.3.406","article-title":"Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators","volume":"99","author":"Krahn","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib150","article-title":"Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope","volume":"4","author":"Solbiati","year":"2016","journal-title":"Cochrane Database Syst. Rev"},{"key":"10.1016\/j.hrthm.2017.10.036_bib151","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/europace\/eut036","article-title":"Tachycardia detection performance of implantable loop recorders: results from a large \u2018real-life\u2019 patient cohort and patients with induced ventricular arrhythmias","volume":"15","author":"Volosin","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib152","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0002-9149(90)90591-N","article-title":"Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope","volume":"66","author":"Linzer","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib153","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.amjcard.2013.04.017","article-title":"Diagnostic utility of a novel leadless arrhythmia monitoring device","volume":"112","author":"Turakhia","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib154","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1056\/NEJMoa043938","article-title":"Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both","volume":"352","author":"Solomon","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib155","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.ahj.2008.08.007","article-title":"Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)","volume":"156","author":"Gula","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib156","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1161\/CIRCULATIONAHA.110.948562","article-title":"OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction","volume":"122","author":"Rauch","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib157","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.jacc.2017.03.003","article-title":"2017 ACC\/AHA\/HRS guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"70","author":"Shen","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib158","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis: a systematic review and meta-analysis","volume":"10","author":"Coleman","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2017.10.036_bib159","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jchf.2016.09.017","article-title":"Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis","volume":"5","author":"Di Marco","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hrthm.2017.10.036_bib160","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2017.10.036_bib161","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCEP.113.000537","article-title":"Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy: implications for the ablation strategy","volume":"6","author":"Piers","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib162","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/CIRCIMAGING.111.966085","article-title":"Utility of cardiovascular magnetic resonance in identifying substrate for malignant ventricular arrhythmias","volume":"5","author":"White","year":"2012","journal-title":"Circ Cardiovasc imaging"},{"key":"10.1016\/j.hrthm.2017.10.036_bib163","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jchf.2013.12.004","article-title":"Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure","volume":"2","author":"Ahmad","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hrthm.2017.10.036_bib164","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/eurjhf\/hfp123","article-title":"Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis","volume":"11","author":"Scott","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hrthm.2017.10.036_bib165","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.hrthm.2014.04.024","article-title":"B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias","volume":"11","author":"Levine","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib166","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1161\/01.CIR.0000016642.15031.34","article-title":"B-type natriuretic peptide predicts sudden death in patients with chronic heart failure","volume":"105","author":"Berger","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib167","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1161\/CIRCULATIONAHA.108.832576","article-title":"Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein as predictors of sudden cardiac death among women","volume":"119","author":"Korngold","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib168","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.hrthm.2010.10.038","article-title":"N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study","volume":"8","author":"Patton","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib169","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.jacc.2013.07.049","article-title":"Cardiomyocyte injury assessed by a highly sensitive troponin assay and sudden cardiac death in the community: the Cardiovascular Health Study","volume":"62","author":"Hussein","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib170","first-page":"1104","article-title":"Mutations in genes encoding cardiac ion channels previously associated with sudden infant death syndrome (SIDS) are present with high frequency in new exome data","volume":"29","author":"Andreasen","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib171","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/CIRCGENETICS.113.000118","article-title":"New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia","author":"Jabbari","year":"2013","journal-title":"Circ Cardiovas Genetics"},{"key":"10.1016\/j.hrthm.2017.10.036_bib172","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/cge.12847","article-title":"Integration of 60,000 exomes and ACMG guidelines question the role of catecholaminergic polymorphic ventricular tachycardia-associated variants","volume":"91","author":"Paludan-Muller","year":"2017","journal-title":"Clin Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib173","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ejhg.2012.23","article-title":"High prevalence of genetic variants previously associated with LQT syndrome in new exome data","volume":"20","author":"Refsgaard","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib174","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/cge.12126","article-title":"High prevalence of genetic variants previously associated with Brugada syndrome in new exome data","volume":"84","author":"Risgaard","year":"2013","journal-title":"Clin Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib175","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.hrthm.2012.01.020","article-title":"Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndrome","volume":"9","author":"Costa","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib176","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cardfail.2009.01.006","article-title":"Genetic evaluation of cardiomyopathy\u2013a Heart Failure Society of America practice guideline","volume":"15","author":"Hershberger","year":"2009","journal-title":"J\u00a0Cardiac Fail"},{"key":"10.1016\/j.hrthm.2017.10.036_bib177","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.hrthm.2010.09.011","article-title":"Trigger-specific risk factors and response to therapy in long QT syndrome type 2","volume":"7","author":"Kim","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib178","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.hrthm.2011.03.049","article-title":"Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome","volume":"8","author":"Migdalovich","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib179","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jacc.2012.04.037","article-title":"Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing","volume":"60","author":"Crotti","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib180","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCGENETICS.109.853374","article-title":"SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome","volume":"2","author":"Probst","year":"2009","journal-title":"Circ Cardiovas Genetics"},{"key":"10.1016\/j.hrthm.2017.10.036_bib181","first-page":"39","article-title":"Genetic variation and the meiotic process","volume":"69","author":"Dintzis","year":"1991","journal-title":"Res Publ Assoc Res Nerv Ment Dis"},{"key":"10.1016\/j.hrthm.2017.10.036_bib182","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCGENETICS.114.001003","article-title":"Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia\/cardiomyopathy patients and family members","volume":"8","author":"Groeneweg","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib183","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jacc.2013.01.073","article-title":"Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians","volume":"61","author":"Marcus","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib184","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1161\/CIRCULATIONAHA.110.976936","article-title":"Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria","volume":"123","author":"Quarta","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib185","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/CIRCGENETICS.113.000288","article-title":"Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy","volume":"6","author":"Rigato","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib186","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/europace\/eur245","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"13","author":"Ackerman","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib187","first-page":"232","article-title":"Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society\/Canadian Heart Rhythm Society joint position paper","volume":"27","author":"Gollob","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib188","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.hrthm.2013.08.022","article-title":"Familial cardiological and targeted genetic evaluation: low yield in sudden unexplained death and high yield in unexplained cardiac arrest syndromes","volume":"10","author":"Kumar","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib189","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib190","doi-asserted-by":"crossref","first-page":"941","DOI":"10.4065\/mcp.2011.0373","article-title":"Unexplained drownings and the cardiac channelopathies: a molecular autopsy series","volume":"86","author":"Tester","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hrthm.2017.10.036_bib191","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00414-016-1424-2","article-title":"The role of known variants of KCNQ1, KCNH2, KCNE1, SCN5A, and NOS1AP in water-related deaths","volume":"130","author":"Tzimas","year":"2016","journal-title":"Int J Legal Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib192","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.forsciint.2014.01.014","article-title":"Cardiac channelopathy testing in 274 ethnically diverse sudden unexplained deaths","volume":"237","author":"Wang","year":"2014","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.hrthm.2017.10.036_bib193","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10897-011-9405-6","article-title":"Family physicians\u2019 awareness and knowledge of the Genetic Information Non-Discrimination Act (GINA)","volume":"21","author":"Laedtke","year":"2012","journal-title":"J\u00a0Genet Couns"},{"key":"10.1016\/j.hrthm.2017.10.036_bib194","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s10897-014-9783-7","article-title":"Disclosing genetic information to family members about inherited cardiac arrhythmias: an obligation or a choice?","volume":"24","author":"Vavolizza","year":"2015","journal-title":"J\u00a0Genet Couns"},{"key":"10.1016\/j.hrthm.2017.10.036_bib195","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/ajmg.a.32915","article-title":"Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: the patients\u2019 perspective","volume":"149a","author":"Christiaans","year":"2009","journal-title":"Am J Med Genet. Part A"},{"key":"10.1016\/j.hrthm.2017.10.036_bib196","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s10897-011-9393-6","article-title":"Predictors of heart-focused anxiety in patients undergoing genetic investigation and counseling of long QT syndrome or hypertrophic cardiomyopathy: a one year follow-up","volume":"21","author":"Hamang","year":"2012","journal-title":"J\u00a0Genet Counsel"},{"key":"10.1016\/j.hrthm.2017.10.036_bib197","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jcin.2016.02.001","article-title":"Emergency PCI in post-cardiac arrest patients without ST-segment elevation pattern: insights from the PROCAT II registry","volume":"9","author":"Dumas","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2017.10.036_bib198","doi-asserted-by":"crossref","DOI":"10.1186\/cc10227","article-title":"Impact of routine percutaneous coronary intervention after out-of-hospital cardiac arrest due to ventricular fibrillation","volume":"15","author":"Cronier","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.hrthm.2017.10.036_bib199","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJM199706053362302","article-title":"Immediate coronary angiography in survivors of out-of-hospital cardiac arrest","volume":"336","author":"Spaulding","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib200","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.amjcard.2012.08.006","article-title":"Impact of emergency coronary angiography on in-hospital outcome of unconscious survivors after out-of-hospital cardiac arrest","volume":"110","author":"Zanuttini","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib201","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O\u2019Gara","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib202","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJM200006293422602","article-title":"Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators","volume":"342","author":"Buxton","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib203","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1161\/01.CIR.0000037224.15873.83","article-title":"Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial","volume":"106","author":"Buxton","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib204","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jacc.2008.08.077","article-title":"The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention","volume":"53","author":"Costantini","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib205","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/0735-1097(91)90802-G","article-title":"Routine programmed electrical stimulation in survivors of acute myocardial infarction for prediction of spontaneous ventricular tachyarrhythmias during follow-up: results, optimal stimulation protocol and cost-effective screening","volume":"18","author":"Bourke","year":"1991","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib206","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/S0735-1097(01)01667-9","article-title":"Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction","volume":"38","author":"Bailey","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib207","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0735-1097(01)01246-3","article-title":"Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers","volume":"37","author":"Schmitt","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib208","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4330\/wjc.v7.i6.344","article-title":"Utility of electrophysiological studies to predict arrhythmic events","volume":"7","author":"Hilfiker","year":"2015","journal-title":"World J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib209","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib210","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","article-title":"A\u00a0randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators","volume":"341","author":"Buxton","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib211","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators","volume":"335","author":"Moss","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib212","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib213","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/01.CIR.71.1.63","article-title":"Electrophysiologic testing in patients with the long QT syndrome","volume":"71","author":"Bhandari","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib214","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/eurheartj\/ehl185","article-title":"Short QT syndrome: clinical findings and diagnostic-therapeutic implications","volume":"27","author":"Giustetto","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib215","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2011.03.038","article-title":"Long-term follow-up of patients with short QT syndrome","volume":"58","author":"Giustetto","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib216","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jacc.2014.10.043","article-title":"Role of electrophysiological studies in predicting risk of ventricular arrhythmia in early repolarization syndrome","volume":"65","author":"Mahida","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib217","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.0000020013.73106.D8","article-title":"Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"106","author":"Priori","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib218","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/CIRCEP.113.000216","article-title":"Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation","volume":"6","author":"Gatzoulis","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib219","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jacc.2004.03.075","article-title":"Differences in mechanisms and outcomes of syncope in patients with coronary disease or idiopathic left ventricular dysfunction as assessed by electrophysiologic testing","volume":"44","author":"Brembilla-Perrot","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib220","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1161\/01.CIR.87.6.1866","article-title":"The long QT syndrome in children. An international study of 287 patients","volume":"87","author":"Garson","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib221","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/jama.296.10.1249","article-title":"Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome","volume":"296","author":"Hobbs","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib222","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/anec.12157","article-title":"Short QT in a cohort of 1.7 million persons: prevalence, correlates, and prognosis","volume":"19","author":"Iribarren","year":"2014","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib223","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.hrthm.2008.02.029","article-title":"Risk of death in the long QT syndrome when a sibling has died","volume":"5","author":"Kaufman","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib224","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/hc3001.093501","article-title":"Clinical implications for affected parents and siblings of probands with long-QT syndrome","volume":"104","author":"Kimbrough","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib225","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jacc.2013.09.078","article-title":"Novel insight into the natural history of short QT syndrome","volume":"63","author":"Mazzanti","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib226","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/CIRCEP.109.907865","article-title":"Utility of treadmill testing in identification and genotype prediction in long-QT syndrome","volume":"3","author":"Wong","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib227","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ahj.2005.02.041","article-title":"Burst bicycle exercise facilitates diagnosis of latent long QT syndrome","volume":"150","author":"Walker","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib228","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1161\/CIRCULATIONAHA.116.021306","article-title":"Global electric heterogeneity risk score for prediction of sudden cardiac death in the general population: the Atherosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies","volume":"133","author":"Waks","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib229","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/jama.292.11.1341","article-title":"Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers","volume":"292","author":"Priori","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib230","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJMoa022147","article-title":"Risk stratification in the long-QT syndrome","volume":"348","author":"Priori","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib231","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00431-008-0896-6","article-title":"QT interval prolongation and risk for cardiac events in genotyped LQTS-index children","volume":"168","author":"Wedekind","year":"2009","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.hrthm.2017.10.036_bib232","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jacc.2010.07.038","article-title":"Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals","volume":"57","author":"Goldenberg","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib233","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/CIRCGENETICS.111.961102","article-title":"Mortality of inherited arrhythmia syndromes: insight into their natural history","volume":"5","author":"Nannenberg","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib234","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/j.1552-4604.1984.tb01822.x","article-title":"A\u00a0classification of antiarrhythmic actions reassessed after a decade of new drugs","volume":"24","author":"Vaughan Williams","year":"1984","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib235","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1517\/14656566.2015.1100170","article-title":"Advances in the pharmacologic treatment of ventricular arrhythmias","volume":"16","author":"Schleifer","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.hrthm.2017.10.036_bib236","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa1514204","article-title":"Amiodarone, lidocaine, or placebo in out-of-hospital cardiac arrest","author":"Kudenchuk","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib237","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","article-title":"Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3","volume":"67","author":"Mazzanti","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib238","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nm.1942","article-title":"Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans","volume":"15","author":"Watanabe","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib239","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2015.03.324","article-title":"Antiarrhythmic properties of ranolazine: a review of the current evidence","volume":"187","author":"Gupta","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib240","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/j.1540-8159.2011.03208.x","article-title":"Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks","volume":"34","author":"Bunch","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib241","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCULATIONAHA.110.937136","volume":"122","author":"Scirica","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib242","article-title":"Ranolazine in High-Risk ICD Patients (RAID) Trial","author":"Zareba","year":"2017","journal-title":"Presented at: Heart Rhythm Society Annual Scientific Sessions"},{"key":"10.1016\/j.hrthm.2017.10.036_bib243","doi-asserted-by":"crossref","first-page":"9I","DOI":"10.1016\/S0002-9149(98)00468-8","article-title":"Importance of beta blockade in the therapy of serious ventricular arrhythmias","volume":"82","author":"Reiter","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib244","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.0000038499.22687.39","article-title":"Effect of beta-blocking therapy on outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT)","volume":"106","author":"Ellison","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib245","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/01.CIR.0000068316.53218.49","article-title":"Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure","volume":"107","author":"Reiken","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib246","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib247","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib248","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The cardiac insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib249","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.1982.03320370021023","article-title":"A\u00a0randomized trial of propranolol in patients with acute myocardial infarction. Mortality results","volume":"247","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib250","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ahj.2011.01.006","article-title":"Treatment and outcomes in patients with myocardial infarction treated with acute beta-blocker therapy: results from the American College of Cardiology\u2019s NCDR(R)","volume":"161","author":"Kontos","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib251","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/01.CIR.102.7.742","article-title":"Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy","volume":"102","author":"Nademanee","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib252","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1067\/mhj.2002.125516","article-title":"Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebo-controlled study","volume":"144","author":"Krittayaphong","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib253","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0002-8703(86)90633-2","article-title":"The role of beta blocking agents as adjunct therapy to membrane stabilizing drugs in malignant ventricular arrhythmia","volume":"111","author":"Hirsowitz","year":"1986","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib254","doi-asserted-by":"crossref","first-page":"90R","DOI":"10.1016\/S0002-9149(99)00708-0","article-title":"Meta-analysis of antiarrhythmic drug trials","volume":"84","author":"Connolly","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib255","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1067\/mhj.2001.117129","article-title":"Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study","volume":"142","author":"Steinberg","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib256","doi-asserted-by":"crossref","first-page":"55D","DOI":"10.1016\/S0002-9149(98)01027-3","article-title":"Amiodarone and \u201cprimary\u201d prevention of sudden death: critical review of a decade of clinical trials","volume":"83","author":"Farre","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib257","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib258","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ahj.2007.09.010","article-title":"Amiodarone use after acute myocardial infarction complicated by heart failure and\/or left ventricular dysfunction may be associated with excess mortality","volume":"155","author":"Thomas","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib259","article-title":"Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death","volume":"12","author":"Claro","year":"2015","journal-title":"Cochrane Database Syst. Rev"},{"key":"10.1016\/j.hrthm.2017.10.036_bib260","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1056\/NEJM199909163411203","article-title":"Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation","volume":"341","author":"Kudenchuk","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib261","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1056\/NEJMoa013029","article-title":"Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation","volume":"346","author":"Dorian","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib262","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0735-1097(95)00427-0","article-title":"Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group","volume":"27","author":"Levine","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib263","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.amjmed.2015.08.039","article-title":"Practical management guide for clinicians who treat patients with amiodarone","volume":"129","author":"Epstein","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib264","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0735-1097(98)00521-X","article-title":"Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment","volume":"33","author":"Kuhlkamp","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib265","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0002-9149(99)80717-6","article-title":"Survival with oral d-sotalol in patients with left ventricular dysfunction after myocardial infarction: rationale, design, and methods (the SWORD trial)","volume":"75","author":"Waldo","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib266","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0002-9149(00)00799-2","article-title":"Effects of antiarrhythmic medication on implantable cardioverter-defibrillator function","volume":"85","author":"Page","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib267","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/0002-9149(87)90857-5","article-title":"Hazards of intravenous verapamil for sustained ventricular tachycardia","volume":"59","author":"Buxton","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib268","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0002-9149(84)80158-7","article-title":"Use of intravenous verapamil for ventricular tachycardia","volume":"54","author":"Belhassen BHorowitz","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib269","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0002-9149(94)90877-X","article-title":"Effects of intravenous adenosine on verapamil-sensitive \u201cidiopathic\u201d ventricular tachycardia","volume":"73","author":"Griffith","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib270","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/0002-8703(93)90664-U","article-title":"Verapamil for the suppression of idiopathic ventricular tachycardia of left bundle branch block-like morphology","volume":"126","author":"Gill","year":"1993","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib271","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cpcardiol.2006.10.002","article-title":"Idiopathic ventricular tachycardia: diagnosis and management","volume":"32","author":"Badhwar","year":"2007","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib272","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1111\/j.1540-8159.1992.tb03033.x","article-title":"Comparison of verapamil and diltiazem in the suppression of idiopathic ventricular tachycardia","volume":"15","author":"Gill","year":"1992","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib273","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0140-6736(02)11278-5","article-title":"Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib274","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/01.CIR.100.12.1311","article-title":"Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction","volume":"100","author":"Cooper","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib275","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archinte.1987.00370030069014","article-title":"Serum magnesium and potassium in acute myocardial infarction. Influence on ventricular arrhythmias","volume":"147","author":"Kafka","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib276","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1161\/01.CIR.98.18.1928","article-title":"Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome","volume":"98","author":"Yan","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib277","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.CIR.77.2.392","article-title":"Treatment of torsade de pointes with magnesium sulfate","volume":"77","author":"Tzivoni","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib278","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/0002-8703(94)90633-5","article-title":"Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia","volume":"128","author":"Leier","year":"1994","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib279","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1001\/archinte.160.16.2429","article-title":"New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice","volume":"160","author":"Cohn","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib280","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jacc.2003.06.021","article-title":"What is the optimal serum potassium level in cardiovascular patients?","volume":"43","author":"Macdonald","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib281","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/jama.2011.1967","article-title":"Serum potassium levels and mortality in acute myocardial infarction","volume":"307","author":"Goyal","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib282","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1161\/01.CIR.0000069566.78305.33","article-title":"Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils","volume":"107","author":"Leaf","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib283","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1001\/jama.296.15.1885","article-title":"Fish intake, contaminants, and human health: evaluating the risks and the benefits","volume":"296","author":"Mozaffarian","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib284","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/01.CIR.0000014682.14181.F2","article-title":"Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto Miocardico (GISSI)-Prevenzione","volume":"105","author":"Marchioli","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib285","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMoa1003603","article-title":"n-3 fatty acids and cardiovascular events after myocardial infarction","volume":"363","author":"Kromhout","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib286","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1161\/CIRCULATIONAHA.110.948562","article-title":"OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction","volume":"122","author":"Rauch","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib287","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.ejcn.1601539","article-title":"Lack of benefit of dietary advice to men with angina: results of a controlled trial","volume":"57","author":"Burr","year":"2003","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.hrthm.2017.10.036_bib288","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c6273","article-title":"Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial","volume":"341","author":"Galan","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2017.10.036_bib289","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa1203859","article-title":"n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia","volume":"367","author":"Bosch","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib290","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.282.24.2340","article-title":"Effect of statins on risk of coronary disease: a meta-analysis of\u00a0randomized controlled trials","volume":"282","author":"LaRosa","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib291","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jacc.2012.03.041","article-title":"Reduction in life-threatening ventricular tachyarrhythmias in statin-treated patients with nonischemic cardiomyopathy enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)","volume":"60","author":"Buber","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib292","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"A\u00a0comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias","volume":"337","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib293","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0735-1097(03)00498-4","article-title":"Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial","volume":"42","author":"Mitchell","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib294","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ahj.2007.02.002","article-title":"Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)","volume":"153","author":"Dickinson","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib295","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.jacc.2006.05.053","article-title":"Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy","volume":"48","author":"Goldberger","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib296","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","article-title":"Rosuvastatin in older patients with systolic heart failure","volume":"357","author":"Kjekshus","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib297","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(08)61240-4","article-title":"Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib298","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jacc.2016.05.011","volume":"68","author":"Yancy","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib299","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The cardiac insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib300","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJM199108013250502","article-title":"A\u00a0comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure","volume":"325","author":"Cohn","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib301","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib302","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib303","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib304","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/1074248413491496","article-title":"Traditional heart failure medications and sudden cardiac death prevention: a review","volume":"18","author":"Al Chekakie","year":"2013","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.hrthm.2017.10.036_bib305","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib306","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.283.10.1295","article-title":"Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR\/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group","volume":"283","author":"Hjalmarson","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib307","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib308","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A\u00a0randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib309","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib310","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib311","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1093\/eurheartj\/ehv186","article-title":"Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients","volume":"36","author":"Desai","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib312","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1161\/CIRCULATIONAHA.107.723551","article-title":"Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus","volume":"116","author":"Zeppenfeld","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib313","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib314","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.hrthm.2009.04.030","volume":"6","author":"Aliot","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib315","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1067\/mhj.2002.121732","article-title":"Effect of surgical revascularization in patients with coronary artery disease and ventricular tachycardia or fibrillation in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry","volume":"143","author":"Cook","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib316","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","article-title":"Coronary-artery bypass surgery in patients with ischemic cardiomyopathy","volume":"374","author":"Velazquez","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib317","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/0735-1097(92)90599-I","article-title":"Influence of coronary bypass surgery on subsequent outcome of patients resuscitated from out of hospital cardiac arrest","volume":"19","author":"Every","year":"1992","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib318","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jcin.2016.02.001","article-title":"Emergency PCI in post-cardiac arrest patients without ST-segment elevation pattern: insights from the PROCAT II registry","volume":"9","author":"Dumas","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2017.10.036_bib319","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.athoracsur.2007.12.035","article-title":"Early and late survival after surgical revascularization for ischemic ventricular fibrillation\/tachycardia","volume":"85","author":"Ngaage","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.hrthm.2017.10.036_bib320","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jacc.2015.10.043","article-title":"Causes of death following PCI versus CABG in complex CAD: 5-year follow-up of SYNTAX","volume":"67","author":"Milojevic","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib321","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jchf.2013.04.012","article-title":"The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results","volume":"1","author":"Carson","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hrthm.2017.10.036_bib322","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0735-1097(00)01136-0","article-title":"Major coronary artery anomalies in a pediatric population: incidence and clinical importance","volume":"37","author":"Davis","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib323","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa1510687","article-title":"A\u00a0prospective study of sudden cardiac death among children and young adults","volume":"374","author":"Bagnall","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib324","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/bjsports-2015-094900","article-title":"Sudden cardiac death associated with physical exertion in the US military, 2005-2010","volume":"50","author":"Smallman","year":"2016","journal-title":"BJ Sports Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib325","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.108.804617","article-title":"Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006","volume":"119","author":"Maron","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib326","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1161\/CIRCULATIONAHA.109.921106","article-title":"Long-term outcome and impact of surgery on adults with coronary arteries originating from the opposite coronary cusp","volume":"123","author":"Krasuski","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib327","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.acra.2016.03.020","article-title":"Anomalous coronary arteries: analysis of clinical outcome based upon arterial course and surgical intervention in an adult population","volume":"23","author":"Layser","year":"2016","journal-title":"Acad Radiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib328","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/0735-1097(92)90019-J","article-title":"Sudden cardiac death associated with isolated congenital coronary artery anomalies","volume":"20","author":"Taylor","year":"1992","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib329","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/CIRCEP.111.962555","article-title":"Surgical ablation of refractory ventricular tachycardia in patients with nonischemic cardiomyopathy","volume":"4","author":"Anter","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib330","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1540-8191.2007.00468.x","article-title":"Surgical options for refractory ventricular tachycardia","volume":"22","author":"Bhavani","year":"2007","journal-title":"J\u00a0Card Surg"},{"key":"10.1016\/j.hrthm.2017.10.036_bib331","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.hrthm.2015.02.016","article-title":"Surgical cryoablation for ventricular tachyarrhythmia arising from the left ventricular outflow tract region","volume":"12","author":"Choi","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib332","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/CIRCEP.114.002522","article-title":"Role of alternative interventional procedures when endo- and epicardial catheter ablation attempts for ventricular arrhythmias fail","volume":"8","author":"Kumar","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib333","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jtcvs.2012.03.061","article-title":"Cryoablation during left ventricular assist device implantation reduces postoperative ventricular tachyarrhythmias","volume":"145","author":"Mulloy","year":"2013","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.hrthm.2017.10.036_bib334","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/jce.12839","article-title":"Safety and feasibility of open chest epicardial mapping and ablation of ventricular tachycardia during the period of left ventricular assist device implantation","volume":"27","author":"Patel","year":"2016","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib335","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.athoracsur.2005.06.058","article-title":"Surgery for ventricular tachycardia in patients undergoing left ventricular reconstruction by the Dor procedure","volume":"81","author":"Sartipy","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.hrthm.2017.10.036_bib336","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1067\/mhj.2002.125516","article-title":"Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebo-controlled study","volume":"144","author":"Krittayaphong","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib337","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1016\/j.jacc.2017.04.035","article-title":"Cardiac sympathetic denervation for refractory ventricular arrhythmias","volume":"69","author":"Vaseghi","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib338","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.hrthm.2013.11.028","article-title":"Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up","volume":"11","author":"Vaseghi","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib339","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1540-8167.1992.tb01090.x","article-title":"Prevention of sudden cardiac death after a first myocardial infarction by pharmacologic or surgical antiadrenergic interventions","volume":"3","author":"Schwartz","year":"1992","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib340","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/CIRCRESAHA.113.302549","article-title":"Role of the autonomic nervous system in modulating cardiac arrhythmias","volume":"114","author":"Shen","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2017.10.036_bib341","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jacc.2011.09.043","article-title":"Bilateral cardiac sympathetic denervation for the management of electrical storm","volume":"59","author":"Ajijola","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"suppl 2","key":"10.1016\/j.hrthm.2017.10.036_bib342","first-page":"S444","article-title":"Part 7: adult advanced cardiovascular life support: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care","volume":"132","author":"Link","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib343","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJMoa040325","article-title":"Advanced cardiac life support in out-of-hospital cardiac arrest","volume":"351","author":"Stiell","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib344","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/CIRCOUTCOMES.109.889576","article-title":"Predictors of survival from out-of-hospital cardiac arrest: a systematic review and meta-analysis","volume":"3","author":"Sasson","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.hrthm.2017.10.036_bib345","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1056\/NEJMoa013029","article-title":"Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation","volume":"346","author":"Dorian","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib346","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa1514204","article-title":"Amiodarone, lidocaine, or placebo in out-of-hospital cardiac arrest","author":"Kudenchuk","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib347","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1056\/NEJM199909163411203","article-title":"Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation","volume":"341","author":"Kudenchuk","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib348","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJM199706053362302","article-title":"Immediate coronary angiography in survivors of out-of-hospital cardiac arrest","volume":"336","author":"Spaulding","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib349","doi-asserted-by":"crossref","DOI":"10.1186\/cc10227","article-title":"Impact of routine percutaneous coronary intervention after out-of-hospital cardiac arrest due to ventricular fibrillation","volume":"15","author":"Cronier","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.hrthm.2017.10.036_bib350","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.amjcard.2012.08.006","article-title":"Impact of emergency coronary angiography on in-hospital outcome of unconscious survivors after out-of-hospital cardiac arrest","volume":"110","author":"Zanuttini","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib351","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jcin.2016.02.001","article-title":"Emergency PCI in post-cardiac arrest patients without ST-segment elevation pattern: insights from the PROCAT II registry","volume":"9","author":"Dumas","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2017.10.036_bib352","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0002-9149(96)00224-X","article-title":"Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia","volume":"78","author":"Gorgels","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib353","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1553-2712.2010.00763.x","article-title":"Procainamide and survival in ventricular fibrillation out-of-hospital cardiac arrest","volume":"17","author":"Markel","year":"2010","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib354","first-page":"1329","article-title":"Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study","volume":"38","author":"Ortiz","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib355","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0300-9572(96)01018-0","article-title":"Lidocaine in out-of-hospital ventricular fibrillation. Does it improve survival?","volume":"33","author":"Herlitz","year":"1997","journal-title":"Resuscitation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib356","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.resuscitation.2013.05.022","article-title":"Prophylactic lidocaine for post resuscitation care of patients with out-of-hospital ventricular fibrillation cardiac arrest","volume":"84","author":"Kudenchuk","year":"2013","journal-title":"Resuscitation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib357","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.1993.03510130095038","article-title":"Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials","volume":"270","author":"Teo","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib358","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/01.CIR.102.7.742","article-title":"Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy","volume":"102","author":"Nademanee","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib359","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.amjcard.2008.07.033","volume":"102","author":"Piccini","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib360","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1001\/jama.1992.03490190067033","article-title":"A\u00a0randomized clinical trial of high-dose epinephrine and norepinephrine vs standard-dose epinephrine in prehospital cardiac arrest","volume":"268","author":"Callaham","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib361","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g3028","article-title":"Time to administration of epinephrine and outcome after in-hospital cardiac arrest with non-shockable rhythms: retrospective analysis of large in-hospital data registry","volume":"348","author":"Donnino","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2017.10.036_bib362","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJM199811263392204","article-title":"A\u00a0comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. European Epinephrine Study Group","volume":"339","author":"Gueugniaud","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib363","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/jama.2012.294","article-title":"Prehospital epinephrine use and survival among patients with out-of-hospital cardiac arrest","volume":"307","author":"Hagihara","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib364","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.resuscitation.2011.06.029","article-title":"Effect of adrenaline on survival in out-of-hospital cardiac arrest: a randomised double-blind placebo-controlled trial","volume":"82","author":"Jacobs","year":"2011","journal-title":"Resuscitation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib365","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.resuscitation.2013.03.023","article-title":"Rapid epinephrine administration improves early outcomes in out-of-hospital cardiac arrest","volume":"84","author":"Koscik","year":"2013","journal-title":"Resuscitation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib366","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(94)91048-0","article-title":"Double-blind trial of lignocaine versus sotalol for acute termination of spontaneous sustained ventricular tachycardia","volume":"344","author":"Ho","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib367","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9149(02)02707-8","article-title":"Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia","volume":"90","author":"Somberg","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib368","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/emj.19.1.57","article-title":"A\u00a0randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation","volume":"19","author":"Hassan","year":"2002","journal-title":"Emerg Med J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib369","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0140-6736(97)05048-4","article-title":"Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff","volume":"350","author":"Thel","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib370","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/euhj.1999.1687","article-title":"Morbidity and mortality following early administration of amiodarone in acute myocardial infarction. GEMICA study investigators, GEMA Group, Buenos Aires, Argentina. Grupo de Estudios Multicentricos en Argentina","volume":"21","author":"Elizari","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib371","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0002-9149(84)80158-7","article-title":"Use of intravenous verapamil for ventricular tachycardia","volume":"54","author":"Belhassen","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib372","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/0002-9149(87)90857-5","article-title":"Hazards of intravenous verapamil for sustained ventricular tachycardia","volume":"59","author":"Buxton","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib373","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1016\/j.jacc.2006.07.010","volume":"48","author":"Zipes","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib374","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/jama.281.13.1182","article-title":"Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation","volume":"281","author":"Cobb","year":"1999","journal-title":"JAMA"},{"issue":"suppl","key":"10.1016\/j.hrthm.2017.10.036_bib375","first-page":"I98","article-title":"Community-based interventions for sudden cardiac death. Impact, limitations, and changes","volume":"85","author":"Cobb","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib376","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1001\/jama.288.23.3035","article-title":"Resuscitation after cardiac arrest: a 3-phase time-sensitive model","volume":"288","author":"Weisfeldt","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib377","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/jama.289.11.1389","article-title":"Delaying defibrillation to give basic cardiopulmonary resuscitation to patients with out-of-hospital ventricular fibrillation: a randomized trial","volume":"289","author":"Wik","year":"2003","journal-title":"JAMA"},{"issue":"suppl 2","key":"10.1016\/j.hrthm.2017.10.036_bib378","first-page":"S729","article-title":"Part 8: adult advanced cardiovascular life support: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care","volume":"122","author":"Neumar","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib379","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1053\/euhj.2000.2476","article-title":"Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs implantable defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study","volume":"21","author":"Connolly","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib380","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jcin.2012.01.017","article-title":"Optimal treatment of patients surviving out-of-hospital cardiac arrest","volume":"5","author":"Kern","year":"2012","journal-title":"JACC Cardiovasc Intervent"},{"key":"10.1016\/j.hrthm.2017.10.036_bib381","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIR.0000000000000144","volume":"132","author":"Perkins","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib382","first-page":"e334","volume":"132","author":"Link","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib383","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMe1602790","article-title":"Out-of-hospital cardiac arrest\u2013are drugs ever the answer?","volume":"374","author":"Joglar","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib384","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"A\u00a0comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias","volume":"337","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib385","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/01.CIR.101.11.1297","article-title":"Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone","volume":"101","author":"Connolly","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib386","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1053\/euhj.2000.2476","article-title":"Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study","volume":"21","author":"Connolly","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib387","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.CIR.102.7.748","article-title":"Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH)","volume":"102","author":"Kuck","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib388","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/01.CIR.103.2.244","article-title":"\u201cStable\u201d ventricular tachycardia is not a benign rhythm: insights from the antiarrhythmics versus implantable defibrillators (AVID) registry","volume":"103","author":"Raitt","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib389","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1067\/mhj.2002.125501","article-title":"Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator","volume":"144","author":"Owens","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib390","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/0002-9149(88)90257-3","article-title":"Long-term prognosis of patients undergoing electrophysiologic studies for syncope of unknown origin","volume":"62","author":"Bass","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib391","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/S0735-1097(01)01597-2","article-title":"Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up","volume":"38","author":"Wyse","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib392","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/eurheartj\/ehu040","article-title":"Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%","volume":"35","author":"Maury","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib393","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/CIRCEP.113.000261","article-title":"A\u00a0stepwise approach to the management of postinfarct ventricular tachycardia using catheter ablation as the first-line treatment: a single-center experience","volume":"6","author":"Pauriah","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib394","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1161\/01.CIR.0000015504.57641.D0","article-title":"Cost-effectiveness of the implantable cardioverter-defibrillator versus antiarrhythmic drugs in survivors of serious ventricular tachyarrhythmias: results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) economic analysis substudy","volume":"105","author":"Larsen","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib395","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1161\/01.CIR.103.10.1416","article-title":"Cost-effectiveness of the implantable cardioverter-defibrillator: results from the Canadian Implantable Defibrillator Study (CIDS)","volume":"103","author":"O\u2019Brien","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib396","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta10270","article-title":"A\u00a0review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context","volume":"10","author":"Buxton","year":"2006","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.hrthm.2017.10.036_bib397","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0002-9343(02)01078-1","article-title":"Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among medicare beneficiaries","volume":"112","author":"Weiss","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib398","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.jacc.2014.03.016","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines","volume":"63","author":"Anderson","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib399","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0735-1097(97)00442-7","article-title":"Arrhythmic cardiac arrest due to isolated coronary\u00a0artery spasm: long-term outcome of seven resuscitated patients","volume":"31","author":"Chevalier","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib400","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJM199205283262202","article-title":"Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm","volume":"326","author":"Myerburg","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib401","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jacc.2016.04.050","article-title":"Prognosis of variant angina manifesting as aborted sudden cardiac death","volume":"68","author":"Ahn","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib402","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jacc.2012.03.070","article-title":"Clinical implications of an implantable cardioverter-defibrillator in patients with vasospastic angina and lethal ventricular arrhythmia","volume":"60","author":"Matsue","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib403","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/CIRCEP.110.959809","article-title":"Clinical characteristics and long-term prognosis of vasospastic angina patients who survived out-of-hospital cardiac arrest: multicenter registry study of the Japanese Coronary Spasm Association","volume":"4","author":"Takagi","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib404","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0002-9149(02)02283-X","article-title":"Usefulness of implantable cardioverter-defibrillators in refractory variant angina pectoris complicated by ventricular fibrillation in patients with angiographically normal coronary arteries","volume":"89","author":"Meisel","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib405","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1253\/circj.CJ-10-74-0802","article-title":"Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008)","volume":"74","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib406","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib407","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1161\/CIR.0b013e3181ce1bcc","article-title":"Letter by Morikawa et\u00a0al regarding article, \u201ccoronary artery spasm: a 2009 update\u201d","volume":"121","author":"Morikawa","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib408","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1253\/circj.CJ-14-1098","article-title":"Usefulness of the wearable cardioverter-defibrillator in patients at high risk for sudden cardiac death","volume":"78","author":"Sasaki","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib409","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.jacc.2003.11.056","article-title":"Predictors of new malignant ventricular arrhythmias after coronary surgery: a case-control study","volume":"43","author":"Ascione","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib410","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0002-9149(99)80566-9","article-title":"Monomorphic versus polymorphic ventricular tachycardia after coronary artery bypass grafting","volume":"75","author":"Saxon","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib411","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1161\/01.CIR.99.7.903","article-title":"New-onset sustained ventricular tachycardia after cardiac surgery","volume":"99","author":"Steinberg","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib412","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1056\/NEJM199711273372201","article-title":"Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators","volume":"337","author":"Bigger","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib413","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.amjcard.2015.12.029","article-title":"Effect of coronary artery bypass grafting on left ventricular ejection fraction in men eligible for implantable cardioverter-defibrillator","volume":"117","author":"Vakil","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib414","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1046\/j.1540-8167.2002.00342.x","article-title":"Prognostic significance of nonsustained ventricular tachycardia after revascularization","volume":"13","author":"Mittal","year":"2002","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib415","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/CIRCEP.112.973552","article-title":"Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator","volume":"6","author":"Zishiri","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib416","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib417","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib418","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators","volume":"335","author":"Moss","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib419","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1067\/mhj.2002.125501","article-title":"Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator","volume":"144","author":"Owens","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib420","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","article-title":"A\u00a0randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators","volume":"341","author":"Buxton","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib421","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1016\/j.transproceed.2013.10.017","article-title":"Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart transplantation","volume":"45","author":"Cantero-P\u00e9rez","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.hrthm.2017.10.036_bib422","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1136\/heartjnl-2013-304185","article-title":"Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation","volume":"99","author":"Frohlich","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2017.10.036_bib423","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.acvd.2016.02.005","article-title":"Implantable cardioverter-defibrillators in end-stage heart failure patients listed for heart transplantation: results from a large retrospective registry","volume":"109","author":"Gandjbakhch","year":"2016","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.hrthm.2017.10.036_bib424","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jacep.2016.07.010","article-title":"Impact of implantable cardioverter-defibrillators on waitlist mortality among patients awaiting heart transplantation: an UNOS\/OPTN analysis","volume":"3","author":"Vakil","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib425","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa041489","article-title":"Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction","volume":"351","author":"Hohnloser","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib426","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1056\/NEJMoa0901889","article-title":"Defibrillator implantation early after myocardial infarction","volume":"361","author":"Steinbeck","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib427","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1161\/01.CIR.97.21.2129","article-title":"The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial","volume":"97","author":"Mushlin","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib428","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.jacc.2006.03.032","article-title":"The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II","volume":"47","author":"Zwanziger","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib429","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/CIRCULATIONAHA.105.581884","article-title":"Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)","volume":"114","author":"Mark","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib430","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/0003-4819-142-8-200504190-00007","article-title":"Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II","volume":"142","author":"Al-Khatib","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib431","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2006.09.020","article-title":"ACC\/AHA\/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Data Standards","volume":"48","author":"Buxton","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib432","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/europace\/eup068","article-title":"Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population","volume":"11","author":"Cowie","year":"2009","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib433","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJMsa051989","article-title":"Cost-effectiveness of implantable cardioverter-defibrillators","volume":"353","author":"Sanders","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib434","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/eurheartj\/ehs090","article-title":"The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis","volume":"34","author":"Smith","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib435","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.jacc.2014.03.016","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines","volume":"63","author":"Anderson","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib436","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJM200006293422602","article-title":"Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators","volume":"342","author":"Buxton","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib437","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1161\/CIRCULATIONAHA.108.836791","article-title":"Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"120","author":"Zaman","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib438","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib439","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jacc.2014.04.008","article-title":"HRS\/ACC\/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials","volume":"64","author":"Kusumoto","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib440","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial","volume":"295","author":"Connolly","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib441","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199906173402402","article-title":"Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group","volume":"340","author":"Pacifico","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib442","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1046\/j.1460-9592.2002.01571.x","article-title":"Efficacy of metoprolol and sotalol in the prevention of recurrences of sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator","volume":"25","author":"Kettering","year":"2002","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib443","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"375","author":"Sapp","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib444","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.hrthm.2010.12.015","article-title":"Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease","volume":"8","author":"Mallidi","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib445","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jacc.2015.11.041","article-title":"Long-term success of irrigated radiofrequency catheter ablation of sustained ventricular tachycardia: post-approval THERMOCOOL VT trial","volume":"67","author":"Marchlinski","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib446","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1161\/CIRCULATIONAHA.108.788604","article-title":"Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial","volume":"118","author":"Stevenson","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib447","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1540-8167.2009.01563.x","article-title":"Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-study","volume":"21","author":"Tanner","year":"2010","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib448","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.hrthm.2015.05.036","article-title":"Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an International VT Ablation Center Collaborative Group study","volume":"12","author":"Tung","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib449","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/jce.12567","article-title":"Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial","volume":"26","author":"Al-Khatib","year":"2015","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib450","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(09)61755-4","article-title":"Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial","volume":"375","author":"Kuck","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib451","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.hrthm.2007.07.013","article-title":"Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy","volume":"4","author":"Sesselberg","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib452","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib453","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/clc.4960220709","article-title":"Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review","volume":"22","author":"Sears","year":"1999","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib454","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1161\/01.CIR.99.7.903","article-title":"New-onset sustained ventricular tachycardia after cardiac surgery","volume":"99","author":"Steinberg","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib455","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0735-1097(00)01133-5","article-title":"Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome","volume":"37","author":"Brugada","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib456","article-title":"Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death","volume":"12","author":"Claro","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hrthm.2017.10.036_bib457","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/j.1540-8159.2011.03208.x","article-title":"Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks","volume":"34","author":"Bunch","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib458","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.hrthm.2007.07.020","article-title":"A\u00a0practical guide for clinicians who treat patients with amiodarone: 2007","volume":"4","author":"Goldschlager","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib459","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199507133330201","article-title":"Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure","volume":"333","author":"Singh","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib460","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM199207233270403","article-title":"Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. The Cardiac Arrhythmia Suppression Trial II Investigators","volume":"327","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib461","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.CIR.102.7.748","article-title":"Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH)","volume":"102","author":"Kuck","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib462","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/clc.4960260303","article-title":"Understanding implantable cardioverter defibrillator shocks and storms: medical and psychosocial considerations for research and clinical care","volume":"26","author":"Sears","year":"2003","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib463","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.hrthm.2009.11.027","article-title":"Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients","volume":"7","author":"Sweeney","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib464","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/eurheartj\/14.10.1297","article-title":"Surgical revascularization in the treatment of ventricular tachycardia and fibrillation exposed by exercise-induced ischaemia","volume":"14","author":"Berntsen","year":"1993","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib465","first-page":"1","article-title":"2015 HRS\/EHRA\/APHRS\/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing","volume":"32","author":"Wilkoff","year":"2016","journal-title":"J\u00a0Arrhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib466","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2017.10.036_bib467","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/CIRCIMAGING.113.001144","article-title":"Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis","volume":"7","author":"Kuruvilla","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2017.10.036_bib468","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCEP.113.000537","article-title":"Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy: implications for the ablation strategy","volume":"6","author":"Piers","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib469","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/europace\/eur245","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"13","author":"Ackerman","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib470","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/GIM.0b013e3181f2481f","article-title":"Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals","volume":"12","author":"Hershberger","year":"2010","journal-title":"Genet Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib471","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis: a systematic review and meta-analysis","author":"Coleman","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2017.10.036_bib472","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.hrthm.2013.06.020","article-title":"Implantable cardioverter-defibrillators in lamin A\/C mutation carriers with cardiac conduction disorders","volume":"10","author":"Anselme","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib473","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2016.08.058","article-title":"Long-term arrhythmic and nonarrhythmic outcomes of lamin A\/C mutation carriers","volume":"68","author":"Kumar","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib474","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMc052632","article-title":"Primary prevention of sudden death in patients with lamin A\/C gene mutations","volume":"354","author":"Meune","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib475","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jacc.2008.06.044","article-title":"Long-term outcome and risk stratification in dilated cardiolaminopathies","volume":"52","author":"Pasotti","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib476","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00109-004-0589-1","article-title":"Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A\/C mutations portend a high risk of sudden death?","volume":"83","author":"Van Berlo","year":"2005","journal-title":"J\u00a0Mol Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib477","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin A\/C mutation carriers: a European cohort study","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib478","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"A\u00a0comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias","volume":"337","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib479","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/01.CIR.101.11.1297","article-title":"Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone","volume":"101","author":"Connolly","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib480","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1001\/jama.292.23.2874","article-title":"Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"292","author":"Desai","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib481","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.CIR.102.7.748","article-title":"Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH)","volume":"102","author":"Kuck","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib482","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/01.CIR.103.2.244","article-title":"\u201cStable\u201d ventricular tachycardia is not a benign rhythm: insights from the Antiarrhythmics versus Implantable Defibrillators (AVID) registry","volume":"103","author":"Raitt","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib483","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1046\/j.1460-9592.2001.01623.x","article-title":"Role of programmed ventricular stimulation and implantable cardioverter defibrillators in patients with idiopathic dilated cardiomyopathy and syncope","volume":"24","author":"Brilakis","year":"2001","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib484","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0002-9149(99)00914-5","article-title":"Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator","volume":"85","author":"Fonarow","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib485","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0735-1097(99)00148-5","article-title":"Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator","volume":"33","author":"Knight","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib486","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0735-1097(93)90724-F","article-title":"Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope","volume":"21","author":"Middlekauff","year":"1993","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib487","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jacc.2007.11.065","article-title":"Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study","volume":"51","author":"Olshansky","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib488","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1161\/CIRCULATIONAHA.113.004196","volume":"129","author":"Ruwald","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib489","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/eurheartj\/ehp100","article-title":"Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials","volume":"30","author":"Piccini","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib490","article-title":"Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death","volume":"12","author":"Claro","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hrthm.2017.10.036_bib491","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1540-8159.2009.02362.x","article-title":"Ventricular arrhythmia inducibility predicts subsequent ICD activation in nonischemic cardiomyopathy patients: a DEFINITE substudy","volume":"32","author":"Daubert","year":"2009","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib492","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/CIRCEP.113.000216","article-title":"Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation","volume":"6","author":"Gatzoulis","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib493","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4330\/wjc.v7.i6.344","article-title":"Utility of electrophysiological studies to predict arrhythmic events","volume":"7","author":"Hilfiker","year":"2015","journal-title":"World J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib494","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ahj.2007.09.010","article-title":"Amiodarone use after acute myocardial infarction complicated by heart failure and\/or left ventricular dysfunction may be associated with excess mortality","volume":"155","author":"Thomas","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib495","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib496","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.0000012350.99718.AD","article-title":"Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT)","volume":"105","author":"B\u00e4nsch","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib497","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib498","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1001\/jama.292.23.2874","article-title":"Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"292","author":"Desai","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib499","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib500","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0735-1097(03)00297-3","article-title":"Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia\u2013AMIOVIRT","volume":"41","author":"Strickberger","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib501","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.hrthm.2013.06.020","article-title":"Implantable cardioverter-defibrillators in lamin A\/C mutation carriers with cardiac conduction disorders","volume":"10","author":"Anselme","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib502","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jacc.2008.06.044","article-title":"Long-term outcome and risk stratification in dilated cardiolaminopathies","volume":"52","author":"Pasotti","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib503","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00109-004-0589-1","article-title":"Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A\/C mutations portend a high risk of sudden death?","volume":"83","author":"Van Berlo","year":"2005","journal-title":"J\u00a0Mol Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib504","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin A\/C mutation carriers: a European cohort study","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib505","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib506","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/jamacardio.2017.0630","article-title":"Primary prevention implantable cardioverter defibillators in patients with nonischemic cardiomyopathy: a meta-analysis","volume":"2","author":"Al-Khatib","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib507","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.116.026056","article-title":"Implantable cardioverter-defibrillator for nonischemic cardiomyopathy: an updated meta-analysis","volume":"135","author":"Golwala","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib508","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial","volume":"295","author":"Connolly","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib509","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.113.003063","article-title":"Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study","volume":"129","author":"Dinov","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib510","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.hrthm.2015.05.036","article-title":"Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an International VT Ablation Center Collaborative Group study","volume":"12","author":"Tung","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib511","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCEP.113.000537","article-title":"Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy: implications for the ablation strategy","volume":"6","author":"Piers","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib512","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/CIRCEP.113.000073","article-title":"Characteristics of intramural scar in patients with nonischemic cardiomyopathy and relation to intramural ventricular arrhythmias","volume":"6","author":"Desjardins","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib513","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/CIRCEP.113.000734","article-title":"Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis","volume":"7","author":"Naruse","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib514","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCGENETICS.114.001003","article-title":"Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia\/cardiomyopathy patients and family members","volume":"8","author":"Groeneweg","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib515","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jacc.2013.01.073","article-title":"Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians","volume":"61","author":"Marcus","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib516","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1161\/CIRCULATIONAHA.110.976936","article-title":"Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria","volume":"123","author":"Quarta","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib517","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/eurheartj\/ehv387","article-title":"Approach to family screening in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"37","author":"te Riele","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib518","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1532-429X-16-47","article-title":"Effect of the 2010 task force criteria on reclassification of cardiovascular magnetic resonance criteria for arrhythmogenic right ventricular cardiomyopathy","volume":"16","author":"Liu","year":"2014","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.hrthm.2017.10.036_bib519","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.108.840827","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the task force criteria","volume":"121","author":"Marcus","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib520","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.jacc.2012.11.087","article-title":"Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated desmosomal mutation carriers","volume":"62","author":"te Riele","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib521","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcmg.2011.01.005","article-title":"Impact of the revision of arrhythmogenic right ventricular cardiomyopathy\/dysplasia task force criteria on its prevalence by CMR criteria","volume":"4","author":"Vermes","year":"2011","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.hrthm.2017.10.036_bib522","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jacc.2011.06.043","article-title":"Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention","volume":"58","author":"Bhonsale","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib523","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1161\/CIRCULATIONAHA.109.913871","article-title":"Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia","volume":"122","author":"Corrado","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib524","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.017944","article-title":"Treatment of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: an international task force consensus statement","volume":"132","author":"Corrado","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib525","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jacc.2014.04.035","article-title":"Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment","volume":"64","author":"Link","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib526","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.hrthm.2005.08.022","article-title":"Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia","volume":"2","author":"Piccini","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib527","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.hrthm.2009.03.013","article-title":"Arrhythmogenic right ventricular cardiomyopathy\/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study","volume":"6","author":"Marcus","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib528","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jacc.2009.04.052","article-title":"Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry","volume":"54","author":"Marcus","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib529","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0735-1097(97)00332-X","article-title":"Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: a multicenter study","volume":"30","author":"Corrado","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib530","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jacc.2013.06.033","article-title":"Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated desmosomal mutation carriers","volume":"62","author":"James","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib531","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/eurheartj\/ehv110","article-title":"Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy","volume":"36","author":"Ruwald","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib532","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/ejhf.181","article-title":"Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members","volume":"16","author":"Saberniak","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hrthm.2017.10.036_bib533","doi-asserted-by":"crossref","first-page":"e001471","DOI":"10.1161\/JAHA.114.001471","article-title":"Exercise has a disproportionate role in the pathogenesis of arrhythmogenic right ventricular dysplasia\/cardiomyopathy in patients without desmosomal mutations","volume":"3","author":"Sawant","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2017.10.036_bib534","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.hrthm.2015.08.035","article-title":"Safety of American Heart Association-recommended minimum exercise for desmosomal mutation carriers","volume":"13","author":"Sawant","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib535","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/eurheartj\/ehu509","article-title":"Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated mutation carriers","volume":"36","author":"Bhonsale","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib536","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCEP.113.000233","article-title":"Risk stratification in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated desmosomal mutation carriers","volume":"6","author":"Bhonsale","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib537","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cardfail.2009.01.006","article-title":"Genetic evaluation of cardiomyopathy\u2013a Heart Failure Society of America practice guideline","volume":"15","author":"Hershberger","year":"2009","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.hrthm.2017.10.036_bib538","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.jacc.2010.12.036","article-title":"Distinguishing arrhythmogenic right ventricular cardiomyopathy\/dysplasia-associated mutations from background genetic noise","volume":"57","author":"Kapplinger","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib539","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/CIRCGENETICS.113.000288","article-title":"Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy","volume":"6","author":"Rigato","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib540","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.hrthm.2014.12.018","article-title":"Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"12","author":"Philips","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib541","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/CIRCEP.111.968677","article-title":"Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"5","author":"Philips","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib542","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jacc.2007.03.049","article-title":"Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"50","author":"Dalal","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib543","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.108.834903","article-title":"Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"120","author":"Garcia","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib544","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/CIRCEP.111.963066","article-title":"Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation","volume":"4","author":"Bai","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib545","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1161\/CIRCEP.110.960740","article-title":"Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique","volume":"5","author":"Berruezo","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib546","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCEP.115.003562","article-title":"Long-term outcome with catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"8","author":"Santangeli","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib547","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/jce.12947","article-title":"Clinical Presentation and Outcomes by Sex in Arrhythmogenic Right Ventricular Cardiomyopathy: findings from the North American ARVC Registry","volume":"27","author":"Choudhary","year":"2016","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib548","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.hrthm.2010.10.007","article-title":"Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"8","author":"Kamath","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib549","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.amjcard.2012.09.025","article-title":"Usefulness of inducible ventricular tachycardia to predict long-term adverse outcomes in arrhythmogenic right ventricular cardiomyopathy","volume":"111","author":"Saguner","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib550","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.jacc.2008.09.019","article-title":"Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity","volume":"52","author":"Sen-Chowdhry","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib551","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/jce.12222","article-title":"Mutation-positive arrhythmogenic right ventricular dysplasia\/cardiomyopathy: the triangle of dysplasia displaced","volume":"24","author":"Te Riele","year":"2013","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib552","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jcmg.2014.09.009","article-title":"Spectrum of biventricular involvement on cmr among carriers of arvd\/c-associated mutations","volume":"8","author":"Rastegar","year":"2015","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.hrthm.2017.10.036_bib553","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1161\/CIRCULATIONAHA.106.660241","article-title":"Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia\/cardiomyopathy provides novel insights into patterns of disease expression","volume":"115","author":"Sen-Chowdhry","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib554","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1161\/CIRCULATIONAHA.105.542266","article-title":"Arrhythmogenic right ventricular dysplasia: a United States experience","volume":"112","author":"Dalal","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib555","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jacep.2016.03.015","article-title":"Risk stratification in arrhythmic right ventricular cardiomyopathy without implantable cardioverter-defibrillators","volume":"2","author":"Brun","year":"2016","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib556","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1161\/01.CIR.0000103130.33451.D2","article-title":"Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"108","author":"Corrado","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib557","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin A\/C mutation carriers: a European cohort study","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib558","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/CIRCULATIONAHA.110.988287","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia\/cardiomyopathy genotype-phenotype follow-up study","volume":"123","author":"Cox","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib559","first-page":"758","article-title":"Role of invasive electrophysiologic testing in risk stratification for sudden cardiac death","volume":"13","author":"Saeed","year":"2001","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib560","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1540-8159.1998.tb01109.x","article-title":"The value of electrophysiology study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy","volume":"21","author":"Zhu","year":"1998","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib561","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.CIR.86.1.29","article-title":"Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia","volume":"86","author":"Wichter","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib562","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0735-1097(99)00056-X","article-title":"Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy","volume":"33","author":"Elliott","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib563","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0735-1097(00)01003-2","article-title":"Sudden death in hypertrophic cardiomyopathy: identification of high risk patients","volume":"36","author":"Elliott","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib564","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(00)04005-8","article-title":"Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy","volume":"357","author":"Elliott","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib565","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/eurheartj\/ehl041","article-title":"Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy","volume":"27","author":"Elliott","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib566","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0002-9149(98)00455-X","article-title":"Predictors of sudden cardiac death in hypertrophic cardiomyopathy","volume":"82","author":"Maki","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib567","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib568","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A\u00a0novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O\u2019Mahony","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib569","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/CIRCULATIONAHA.108.798314","article-title":"Syncope and risk of sudden death in hypertrophic cardiomyopathy","volume":"119","author":"Spirito","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib570","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/hrt.2010.217182","article-title":"The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy","volume":"98","author":"O\u2019Mahony","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2017.10.036_bib571","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1540-8167.2009.01716.x","article-title":"Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up","volume":"21","author":"Syska","year":"2010","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib572","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.amjcard.2006.07.029","article-title":"Determinants for clinical diagnosis of hypertrophic cardiomyopathy","volume":"98","author":"Adabag","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib573","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jcmg.2008.09.002","article-title":"Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologies","volume":"1","author":"Afonso","year":"2008","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.hrthm.2017.10.036_bib574","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2009.11.062","article-title":"Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations","volume":"55","author":"Girolami","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib575","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/gim.2013.44","article-title":"Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy","volume":"15","author":"Ingles","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib576","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.111.090514","article-title":"Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing","volume":"127","author":"Jensen","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib577","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/0735-1097(95)00390-8","article-title":"Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients","volume":"26","author":"Klues","year":"1995","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib578","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1161\/01.CIR.92.7.1680","article-title":"Hypertrophic cardiomyopathy. Clinical spectrum and treatment","volume":"92","author":"Wigle","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib579","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/eurheartj\/ehp539","article-title":"The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening","volume":"31","author":"Christiaans","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib580","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0025-6196(11)60890-2","article-title":"Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy","volume":"83","author":"Olivotto","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hrthm.2017.10.036_bib581","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/ajmg.a.32915","article-title":"Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: the patients\u2019 perspective","volume":"149a","author":"Christiaans","year":"2009","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib582","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s10897-011-9393-6","article-title":"Predictors of heart-focused anxiety in patients undergoing genetic investigation and counseling of long QT syndrome or hypertrophic cardiomyopathy: a one year follow-up","volume":"21","author":"Hamang","year":"2012","journal-title":"J\u00a0Genet Counsel"},{"key":"10.1016\/j.hrthm.2017.10.036_bib583","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.mayocp.2014.01.025","article-title":"Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy","volume":"89","author":"Bos","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hrthm.2017.10.036_bib584","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.echo.2006.01.005","article-title":"Use of echocardiography in patients with hypertrophic cardiomyopathy: clinical implications of massive hypertrophy","volume":"19","author":"Sorajja","year":"2006","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.hrthm.2017.10.036_bib585","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","article-title":"Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy","volume":"342","author":"Spirito","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib586","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.amjcard.2010.06.077","article-title":"Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy","volume":"106","author":"Bos","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib587","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM200002103420601","article-title":"Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy","volume":"342","author":"Maron","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib588","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","article-title":"Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients","volume":"42","author":"Monserrat","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib589","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/S0735-1097(99)00094-7","article-title":"Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy","volume":"33","author":"Olivotto","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib590","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1161\/01.CIR.96.9.2987","article-title":"Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy","volume":"96","author":"Sadoul","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib591","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/hrt.53.4.412","article-title":"Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia","volume":"53","author":"McKenna","year":"1985","journal-title":"Br Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib592","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/hrt.2006.099416","article-title":"Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy","volume":"93","author":"Melacini","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2017.10.036_bib593","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/oxfordjournals.eurheartj.a062472","article-title":"Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope","volume":"9","author":"Kuck","year":"1988","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib594","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1540-8159.1998.tb01109.x","article-title":"The value of electrophysiology study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy","volume":"21","author":"Zhu","year":"1998","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib595","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0735-1097(02)01900-9","article-title":"Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective","volume":"39","author":"Ackerman","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib596","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1136\/heartjnl-2013-303939","article-title":"A\u00a0systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations","volume":"99","author":"Lopes","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2017.10.036_bib597","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","volume":"58","author":"Gersh","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib598","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jcmg.2011.11.021","article-title":"Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy","volume":"5","author":"Green","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2017.10.036_bib599","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","article-title":"Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"56","author":"O\u2019Hanlon","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib600","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCHEARTFAILURE.109.854026","article-title":"Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy","volume":"3","author":"Rubinshtein","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hrthm.2017.10.036_bib601","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jacc.2016.11.063","article-title":"Hypertrophic cardiomyopathy with left ventricular apical aneurysm: implications for risk stratification and management","volume":"69","author":"Rowin","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib602","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.112.136085","article-title":"Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age","volume":"127","author":"Maron","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib603","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/jce.12714","article-title":"Eligibility for the subcutaneous implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy","volume":"26","author":"Francia","year":"2015","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib604","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/eurheartj\/ehr092","article-title":"Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy","volume":"32","author":"Christiaans","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib605","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa075463","article-title":"Shared genetic causes of cardiac hypertrophy in children and adults","volume":"358","author":"Morita","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib606","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJM199804303381802","article-title":"Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy","volume":"338","author":"Niimura","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib607","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/eurheartj\/ehq111","article-title":"Emergence of gene mutation carriers and the expanding disease spectrum of hypertrophic cardiomyopathy","volume":"31","author":"Maron","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib608","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.amjcard.2010.10.022","article-title":"Clinical challenges of genotype positive (+)-phenotype negative (-) family members in hypertrophic cardiomyopathy","volume":"107","author":"Maron","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib609","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1136\/jmg.2005.033886","article-title":"Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling","volume":"42","author":"Ingles","year":"2005","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib610","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1056\/NEJM199112193252501","article-title":"Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes","volume":"325","author":"Rosenzweig","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib611","doi-asserted-by":"crossref","first-page":"e003818","DOI":"10.1161\/CIRCEP.115.003818","article-title":"Inverted U-shaped relation between the risk of sudden cardiac death and maximal left ventricular wall thickness in hypertrophic cardiomyopathy","volume":"9","author":"O\u2019Mahony","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib612","first-page":"758","article-title":"Role of invasive electrophysiologic testing in risk stratification for sudden cardiac death","volume":"13","author":"Saeed","year":"2001","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib613","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.amjcard.2014.02.032","article-title":"Hypertrophic cardiomyopathy: one gene \u2026 but many phenotypes","volume":"113","author":"Maron","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib614","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1136\/heartjnl-2016-310015","article-title":"Evolution of hypertrophic cardiomyopathy in sarcomere mutation carriers","volume":"102","author":"Ho","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2017.10.036_bib615","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0735-1097(03)00189-X","article-title":"Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance","volume":"41","author":"Moon","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib616","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.108.781401","article-title":"Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy","volume":"118","author":"Maron","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib617","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/j.jacc.2011.02.033","article-title":"Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy","volume":"57","author":"Minami","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib618","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1253\/circj.66.133","article-title":"National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee)","volume":"66","author":"Aoyama","year":"2002","journal-title":"Circ J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib619","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.amjcard.2015.03.023","article-title":"Long-term risk of recurrence, morbidity and mortality in giant cell myocarditis","volume":"115","author":"Maleszewski","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib620","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJM199706263362603","article-title":"Idiopathic giant-cell myocarditis\u2013natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators","volume":"336","author":"Cooper","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib621","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/CIRCHEARTFAILURE.112.969261","article-title":"Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression","volume":"6","author":"Kandolin","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"suppl O","key":"10.1016\/j.hrthm.2017.10.036_bib622","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/eurheartj\/16.suppl_O.36","article-title":"The epidemiology of infectious myocarditis, lymphocytic myocarditis and dilated cardiomyopathy","volume":"16","author":"Friman","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib623","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s000590050021","article-title":"The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results","volume":"25","author":"Hufnagel","year":"2000","journal-title":"Herz"},{"key":"10.1016\/j.hrthm.2017.10.036_bib624","first-page":"455","article-title":"Myocarditis. Curr Treat Options","volume":"4","author":"Winkel","year":"2002","journal-title":"Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib625","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1177\/0961203312456752","article-title":"A\u00a0contemporary case series of lupus myocarditis","volume":"21","author":"Zawadowski","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.hrthm.2017.10.036_bib626","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib627","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/heartjnl-2012-301686","article-title":"Pathogenesis and diagnosis of myocarditis","volume":"98","author":"Elamm","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2017.10.036_bib628","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0140-6736(11)60648-X","volume":"379","author":"Sagar","year":"2012","journal-title":"Myocarditis. Lancet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib629","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1056\/NEJM200003093421003","article-title":"Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis","volume":"342","author":"McCarthy","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib630","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.CIR.99.8.1091","article-title":"From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future","volume":"99","author":"Kawai","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib631","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1161\/CIRCULATIONAHA.108.769489","article-title":"Predictors of outcome in patients with suspected myocarditis","volume":"118","author":"Kindermann","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib632","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1651-2227.1990.tb11516.x","article-title":"Ventricular tachycardia associated with Coxsackie B4 virus infection","volume":"79","author":"Tubman","year":"1990","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.hrthm.2017.10.036_bib633","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000175023","article-title":"Incessant automatic ventricular tachycardia complicating acute coxsackie B myocarditis","volume":"80","author":"Tai","year":"1992","journal-title":"Cardiology"},{"key":"10.1016\/j.hrthm.2017.10.036_bib634","first-page":"336","article-title":"Recurrent seizures and syncope, ventricular arrhythmias with reversible prolonged Q-Tc interval in typhoid myocarditis","volume":"85","author":"Dhar","year":"1987","journal-title":"J\u00a0Indian Med Assoc"},{"key":"10.1016\/j.hrthm.2017.10.036_bib635","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs033","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hrthm.2017.10.036_bib636","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00059-012-3658-1","article-title":"Giant cell myocarditis. Diagnosis and treatment","volume":"37","author":"Cooper","year":"2012","journal-title":"Herz"},{"key":"10.1016\/j.hrthm.2017.10.036_bib637","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/clc.4960210704","article-title":"Cardiac involvement in acquired immunodeficiency syndrome\u2013a review to push action. The Committee for the Study of Cardiac Involvement in AIDS","volume":"21","author":"Milei","year":"1998","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib638","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00042560-199806010-00006","article-title":"Cardiac manifestations of HIV\/AIDS: a review of disease spectrum and clinical management","volume":"18","author":"Yunis","year":"1998","journal-title":"J\u00a0Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib639","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00296-011-2240-0","article-title":"Acute myocarditis and ventricular fibrillation as initial presentation of pediatric systemic lupus erythematosus","volume":"33","author":"Huang","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.hrthm.2017.10.036_bib640","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/clc.4960231205","article-title":"Chagas\u2019 heart disease","volume":"23","author":"Rassi","year":"2000","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib641","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1540-8159.1997.tb04841.x","article-title":"Implantable cardioverter defibrillators in patients with Chagas\u2019 disease: are they different from patients with coronary disease?","volume":"20","author":"Muratore","year":"1997","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib642","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1023\/A:1020811915133","article-title":"New perspectives on catheter-based ablation of ventricular tachycardia complicating Chagas\u2019 disease: experimental evidence of the efficacy of near infrared lasers for catheter ablation of Chagas\u2019 VT","volume":"7","author":"d\u2019Avila","year":"2002","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib643","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2261-12-123","article-title":"Wearable defibrillator use in heart failure (WIF): results of a prospective registry","volume":"12","author":"Kao","year":"2012","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.hrthm.2017.10.036_bib644","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1540-8159.2004.00378.x","article-title":"Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT\/BIROAD","volume":"27","author":"Feldman","year":"2004","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib645","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11936-001-0020-y","article-title":"Idiopathic giant cell myocarditis","volume":"3","author":"Cooper","year":"2001","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib646","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib647","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib648","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/europace\/eus316","article-title":"Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"15","author":"Kron","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib649","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/jce.12302","article-title":"Cardiac sarcoidosis: electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator","volume":"25","author":"Mohsen","year":"2014","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib650","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1540-8167.2012.02350.x","article-title":"Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis","volume":"23","author":"Schuller","year":"2012","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib651","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis: a systematic review and meta-analysis","volume":"10","author":"Coleman","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2017.10.036_bib652","doi-asserted-by":"crossref","first-page":"e003738","DOI":"10.1161\/CIRCIMAGING.115.003738","article-title":"Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction: risk stratification using cardiovascular magnetic resonance","volume":"9","author":"Murtagh","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2017.10.036_bib653","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCEP.113.000156","article-title":"Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias","volume":"7","author":"Crawford","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib654","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2017.10.036_bib655","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib656","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.amjcard.2005.03.059","article-title":"Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis","volume":"96","author":"Aizer","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib657","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1001\/jama.2009.600","article-title":"Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention","volume":"301","author":"Mehta","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib658","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.amjcard.2014.11.028","article-title":"Outcomes in patients with high-degree atrioventricular block as the initial manifestation of cardiac sarcoidosis","volume":"115","author":"Takaya","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib659","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/CIRCEP.113.000734","article-title":"Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis","volume":"7","author":"Naruse","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib660","doi-asserted-by":"crossref","first-page":"e003353","DOI":"10.1161\/CIRCEP.115.003353","article-title":"Time course and factors correlating with ventricular tachyarrhythmias after introduction of steroid therapy in cardiac sarcoidosis","volume":"9","author":"Segawa","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib661","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1542-474X.2011.00418.x","article-title":"Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"16","author":"Yodogawa","year":"2011","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib662","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib663","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCEP.110.958322","article-title":"Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation","volume":"4","author":"Mehta","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib664","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pcad.2007.10.003","article-title":"Sudden cardiac death in infiltrative cardiomyopathies: sarcoidosis, scleroderma, amyloidosis, hemachromatosis","volume":"51","author":"Lubitz","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.hrthm.2017.10.036_bib665","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.hrthm.2007.10.016","article-title":"Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death","volume":"5","author":"Kristen","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib666","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.jacc.2016.03.593","article-title":"Efficacy of chemotherapy for light-chain amyloidosis in patients presenting with symptomatic heart failure","volume":"67","author":"Sperry","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib667","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.hrthm.2013.10.026","article-title":"Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis","volume":"11","author":"Varr","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib668","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1136\/heartjnl-2013-304185","article-title":"Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure\u00a0awaiting heart transplantation","volume":"99","author":"Frohlich","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2017.10.036_bib669","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2261-12-123","article-title":"Wearable defibrillator use in heart failure (WIF): results of a\u00a0prospective registry","volume":"12","author":"Kao","year":"2012","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.hrthm.2017.10.036_bib670","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.healun.2015.04.004","article-title":"Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: a national database analysis","volume":"34","author":"Opreanu","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hrthm.2017.10.036_bib671","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/hc37t1.094916","article-title":"Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation","volume":"104","author":"Sandner","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib672","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jacep.2016.07.010","article-title":"Impact of implantable cardioverter-defibrillators on waitlist mortality among patients awaiting heart transplantation. An UNOS\/OPTN Analysis","volume":"3","author":"Vakil","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib673","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1161\/CIRCULATIONAHA.109.853689","article-title":"Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial","volume":"120","author":"Packer","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib674","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib675","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/01.CIR.80.6.1675","article-title":"Diverse mechanisms of unexpected cardiac arrest in advanced heart failure","volume":"80","author":"Luu","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib676","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/oxfordjournals.eurheartj.a015074","article-title":"Mode of death in chronic heart failure. A request and proposition for more accurate classification","volume":"17","author":"Narang","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib677","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/archinte.160.5.621","article-title":"Beta-adrenergic blocking agents in heart failure: benefits of vasodilating and non-vasodilating agents according to patients\u2019 characteristics: a meta-analysis of clinical trials","volume":"160","author":"Bonet","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib678","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib679","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1093\/eurheartj\/ehv186","article-title":"Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients","volume":"36","author":"Desai","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib680","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib681","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/01.RES.0000145047.14691.db","article-title":"What causes sudden death in heart failure?","volume":"95","author":"Tomaselli","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2017.10.036_bib682","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.CIR.97.2.155","article-title":"Family history as a risk factor for primary cardiac arrest","volume":"97","author":"Friedlander","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib683","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1113\/JP271992","article-title":"Arrhythmogenic and metabolic remodelling of failing human heart","volume":"594","author":"Gloschat","year":"2016","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib684","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jchf.2016.05.003","article-title":"Implantable cardioverter-defibrillator use in patients with left ventricular assist devices: a systematic review and meta-analysis","volume":"4","author":"Vakil","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hrthm.2017.10.036_bib685","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib686","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cardfail.2012.08.357","article-title":"Sudden cardiac death in heart failure patients with preserved ejection fraction","volume":"18","author":"Adabag","year":"2012","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.hrthm.2017.10.036_bib687","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib688","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib689","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib690","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1540-8167.2007.00957.x","article-title":"Incidence and predictors of sudden cardiac death in patients with diastolic heart failure","volume":"18","author":"Al-Khatib","year":"2007","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib691","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1161\/01.CIR.92.2.231","article-title":"Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death","volume":"92","author":"Gatzoulis","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib692","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.ijcard.2014.08.068","article-title":"Prognostic value of programmed ventricular stimulation for sudden death in selected high risk patients with structural heart disease and preserved systolic function","volume":"176","author":"Gatzoulis","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib693","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jchf.2016.05.003","article-title":"Implantable cardioverter-defibrillator use in patients with left ventricular assist devices: a systematic review and meta-analysis","volume":"4","author":"Vakil","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hrthm.2017.10.036_bib694","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.hrthm.2009.12.022","article-title":"Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator","volume":"7","author":"Cantillon","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib695","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ahj.2012.06.018","article-title":"Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation","volume":"164","author":"Raasch","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib696","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.jacc.2013.04.020","article-title":"Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention?","volume":"61","author":"Garan","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib697","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.cardfail.2011.10.020","article-title":"Survival benefit of implantable cardioverter-defibrillators in left ventricular assist device-supported heart failure patients","volume":"18","author":"Refaat","year":"2012","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.hrthm.2017.10.036_bib698","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/CIRCEP.113.000457","article-title":"The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices","volume":"6","author":"Enriquez","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib699","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/pace.12654","article-title":"Impact of implantable cardioverter defibrillators on survival of patients with centrifugal left ventricular assist devices","volume":"38","author":"Lee","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib700","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.jacc.2014.01.053","article-title":"Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support)","volume":"63","author":"Jorde","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib701","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/HCO.0b013e328345aff4","article-title":"Destination therapy with left ventricular assist devices: patient selection and outcomes","volume":"26","author":"Slaughter","year":"2011","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib702","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/CIRCHEARTFAILURE.108.814525","article-title":"The efficacy of implantable cardioverter-defibrillators in heart transplant recipients: results from a multicenter registry","volume":"2","author":"Tsai","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hrthm.2017.10.036_bib703","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.healun.2009.04.016","article-title":"Implantable defibrillators and cardiac resynchronization therapy in heart transplant recipients: results of a national survey","volume":"28","author":"McDowell","year":"2009","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hrthm.2017.10.036_bib704","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.healun.2015.12.011","article-title":"Implantable cardioverter-defibrillators in a heart transplant population: A single-center experience","volume":"35","author":"Neylon","year":"2016","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hrthm.2017.10.036_bib705","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.hrthm.2014.07.016","article-title":"Incidence, predictors, and temporal trends of sudden cardiac death after heart transplantation","volume":"11","author":"Vakil","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib706","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.hrthm.2009.01.005","article-title":"Mode and mechanisms of death after orthotopic heart transplantation","volume":"6","author":"Vaseghi","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib707","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.ahj.2010.07.032","article-title":"Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1","volume":"160","author":"Bhakta","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib708","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/01.CIR.98.6.541","article-title":"Mechanisms of sustained ventricular tachycardia in myotonic dystrophy: implications for catheter ablation","volume":"98","author":"Merino","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib709","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.hrthm.2013.06.020","article-title":"Implantable cardioverter-defibrillators in lamin A\/C mutation carriers with cardiac conduction disorders","volume":"10","author":"Anselme","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib710","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin A\/C mutation carriers: a European cohort study","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib711","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMc052632","article-title":"Primary prevention of sudden death in patients with lamin A\/C gene mutations","volume":"354","author":"Meune","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib712","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jacc.2008.06.044","article-title":"Long-term outcome and risk stratification in dilated cardiolaminopathies","volume":"52","author":"Pasotti","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib713","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00109-004-0589-1","article-title":"Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A\/C mutations portend a high risk of sudden death?","volume":"83","author":"Van Berlo","year":"2005","journal-title":"J\u00a0Mol Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib714","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/europace\/euu146","article-title":"ICD role in preventing sudden cardiac death in Emery-Dreifuss muscular dystrophy with preserved myocardial function: 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy","volume":"17","author":"Russo","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib715","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1056\/NEJMoa062800","article-title":"Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1","volume":"358","author":"Groh","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib716","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/heartjnl-2011-300143","article-title":"The evolution of infrahissian conduction time in myotonic dystrophy patients: clinical implications","volume":"98","author":"Lallemand","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2017.10.036_bib717","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1540-8159.2010.02905.x","article-title":"Clinical predictors of conduction disease progression in type I myotonic muscular dystrophy","volume":"34","author":"Nazarian","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib718","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamacardio.2016.4145","article-title":"Left ventricular dysfunction and conduction disturbances in patients with myotonic muscular dystrophy type I and II","volume":"2","author":"Tanawuttiwat","year":"2017","journal-title":"JAMA Cardiology"},{"key":"10.1016\/j.hrthm.2017.10.036_bib719","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1540-8167.2011.02200.x","article-title":"Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population","volume":"22","author":"Bhakta","year":"2011","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib720","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijcard.2010.02.029","article-title":"Mortality in myotonic dystrophy patients in the area of prophylactic pacing devices","volume":"150","author":"Laurent","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib721","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.hrthm.2012.06.038","article-title":"Arrhythmias in the muscular dystrophies","volume":"9","author":"Groh","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib722","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","volume":"51","author":"Epstein","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib723","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2016.08.058","article-title":"Long-term arrhythmic and nonarrhythmic outcomes of lamin A\/C mutation carriers","volume":"68","author":"Kumar","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib724","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/europace\/euq423","article-title":"Long-term follow-up of patients with myotonic dystrophy: an electrocardiogram every year is not necessary","volume":"13","author":"Brembilla-Perrot","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib725","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1540-8159.2012.03351.x","article-title":"Predictors of atrio-ventricular conduction disease, long-term outcomes in patients with myotonic dystrophy types I and II","volume":"35","author":"Ha","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib726","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCEP.108.782888","article-title":"Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing","volume":"2","author":"Bai","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib727","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jacc.2010.07.038","article-title":"Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals","volume":"57","author":"Goldenberg","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib728","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/CIRCGENETICS.111.961102","article-title":"Mortality of inherited arrhythmia syndromes: insight into their natural history","volume":"5","author":"Nannenberg","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib729","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jacc.2011.08.064","article-title":"Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry","volume":"59","author":"Priori","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib730","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.0000020013.73106.D8","article-title":"Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"106","author":"Priori","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib731","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCULATIONAHA.116.021823","article-title":"Clinical aspects of type 3 long-QT syndrome: an international multicenter study","volume":"134","author":"Wilde","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib732","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00431-008-0896-6","article-title":"QT interval prolongation and risk for cardiac events in genotyped LQTS-index children","volume":"168","author":"Wedekind","year":"2009","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.hrthm.2017.10.036_bib733","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1161\/01.CIR.101.6.616","article-title":"Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome","volume":"101","author":"Moss","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib734","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1540-8167.2003.02545.x","article-title":"Implantable cardioverter defibrillator in high-risk long QT syndrome patients","volume":"14","author":"Zareba","year":"2003","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib735","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.hrthm.2005.02.008","article-title":"Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: a long-term follow-up","volume":"2","author":"Monnig","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib736","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.108.829267","article-title":"Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia","volume":"119","author":"Hayashi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib737","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1540-8167.2006.00455.x","article-title":"Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis","volume":"17","author":"Gehi","year":"2006","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib738","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.109.887026","article-title":"Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada syndrome registry","volume":"121","author":"Probst","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib739","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/eurheartj\/ehq381","article-title":"Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach","volume":"32","author":"Delise","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib740","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jelectrocard.2013.04.003","article-title":"Prognosis and risk stratification of young adults with Brugada syndrome","volume":"46","author":"Hiraoka","year":"2013","journal-title":"J\u00a0Electrocardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib741","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.hrthm.2008.02.029","article-title":"Risk of death in the long QT syndrome when a sibling has died","volume":"5","author":"Kaufman","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib742","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/hc3001.093501","article-title":"Clinical implications for affected parents and siblings of probands with long-QT syndrome","volume":"104","author":"Kimbrough","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib743","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1161\/hc1102.105288","article-title":"Natural history of Brugada syndrome: insights for risk stratification and management","volume":"105","author":"Priori","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib744","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/jama.296.10.1249","article-title":"Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome","volume":"296","author":"Hobbs","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib745","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/jama.292.11.1341","article-title":"Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers","volume":"292","author":"Priori","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib746","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJMoa022147","article-title":"Risk stratification in the long-QT syndrome","volume":"348","author":"Priori","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib747","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jacc.2009.05.029","article-title":"Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy","volume":"54","author":"Spazzolini","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib748","unstructured":"Credible meds. Available at: http:\/\/www.crediblemeds.org. Accessed December 26,\u00a02016."},{"key":"10.1016\/j.hrthm.2017.10.036_bib749","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/cge.12847","article-title":"Integration of 60,000 exomes and ACMG guidelines question the role of catecholaminergic polymorphic ventricular tachycardia-associated variants","volume":"91","author":"Paludan-Muller","year":"2017","journal-title":"Clin Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib750","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2011.03.038","article-title":"Long-term follow-up of patients with short QT syndrome","volume":"58","author":"Giustetto","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib751","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jacc.2014.10.043","article-title":"Role of electrophysiological studies in predicting risk of ventricular arrhythmia in early repolarization syndrome","volume":"65","author":"Mahida","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib752","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jacc.2013.09.078","article-title":"Novel insight into the natural history of short QT syndrome","volume":"63","author":"Mazzanti","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib753","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/europace\/euv301","article-title":"Early repolarization pattern is the strongest predictor of arrhythmia recurrence in patients with idiopathic ventricular fibrillation: results from a single centre long-term follow-up over 20 years","volume":"18","author":"Siebermair","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib754","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jacc.2007.05.042","article-title":"Long QT syndrome in children in the era of implantable defibrillators","volume":"50","author":"Etheridge","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib755","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.hrthm.2010.08.023","article-title":"Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience","volume":"7","author":"Horner","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib756","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1540-8159.2009.02302.x","article-title":"Use of implantable cardioverter-defibrillator in inherited arrhythmogenic diseases: data from Italian ICD Registry for the years 2001-6","volume":"32","author":"Proclemer","year":"2009","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib757","doi-asserted-by":"crossref","first-page":"e003440","DOI":"10.1161\/CIRCEP.115.003440","article-title":"Patient outcomes from a specialized inherited arrhythmia clinic","volume":"9","author":"Adler","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib758","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jacc.2014.12.031","article-title":"Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience","volume":"65","author":"Conte","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib759","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.hrthm.2015.09.010","article-title":"Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications","volume":"13","author":"Olde Nordkamp","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib760","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.hrthm.2015.10.038","article-title":"Monomorphic ventricular tachycardia in patients with Brugada syndrome: a multicenter retrospective study","volume":"13","author":"Rodriguez-Manero","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib761","first-page":"435","article-title":"Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU)","volume":"10","author":"Rosso","year":"2008","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib762","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1161\/01.CIR.100.24.2431","article-title":"Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing","volume":"100","author":"Dorostkar","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib763","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/0735-1097(92)90180-U","article-title":"Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome","volume":"20","author":"Eldar","year":"1992","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib764","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1161\/01.CIR.84.4.1524","article-title":"Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome","volume":"84","author":"Moss","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib765","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/CIRCULATIONAHA.108.772533","article-title":"High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment \u201cfailures\u201d.","volume":"119","author":"Vincent","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib766","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2014.05.068","article-title":"Efficacy of different beta-blockers in the treatment of long QT syndrome","volume":"64","author":"Abu-Zeitone","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib767","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1540-8167.2010.01737.x","article-title":"Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management","volume":"21","author":"Goldenberg","year":"2010","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib768","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1161\/01.CIR.101.6.616","article-title":"Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome","volume":"101","author":"Moss","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib769","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2006.08.057","article-title":"Long QT\u00a0syndrome in adults","volume":"49","author":"Sauer","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib770","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/CIRCULATIONAHA.108.772533","article-title":"High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment \u201cfailures\u201d.","volume":"119","author":"Vincent","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib771","doi-asserted-by":"crossref","first-page":"e004370","DOI":"10.1161\/CIRCEP.116.004370","article-title":"Ranolazine for congenital long-qt syndrome type III: experimental and long-term clinical data","volume":"9","author":"Chorin","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib772","article-title":"Long-term flecainide therapy in type 3 long QT syndrome","author":"Chorin","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib773","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/jama.296.10.1249","article-title":"Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome","volume":"296","author":"Hobbs","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib774","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jacc.2009.11.042","article-title":"Risk of fatal arrhythmic events in long QT syndrome patients after syncope","volume":"55","author":"Jons","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib775","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","article-title":"Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3","volume":"67","author":"Mazzanti","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib776","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/CIRCGENETICS.111.961102","article-title":"Mortality of inherited arrhythmia syndromes: insight into their natural history","volume":"5","author":"Nannenberg","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib777","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00431-008-0896-6","article-title":"QT interval prolongation and risk for cardiac events in genotyped LQTS-index children","volume":"168","author":"Wedekind","year":"2009","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.hrthm.2017.10.036_bib778","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.hrthm.2009.03.024","article-title":"Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery","volume":"6","author":"Collura","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib779","first-page":"404","article-title":"Left thoracoscopic sympathectomy for cardiac denervation in patients with life-threatening ventricular arrhythmias. J Thorac Cardiovasc","volume":"147","author":"Hofferberth","year":"2014","journal-title":"Surg"},{"key":"10.1016\/j.hrthm.2017.10.036_bib780","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00392-012-0492-7","article-title":"Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome","volume":"102","author":"Schneider","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib781","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/01.CIR.0000125523.14403.1E","article-title":"Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome","volume":"109","author":"Schwartz","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib782","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCEP.108.782888","article-title":"Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing","volume":"2","author":"Bai","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib783","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.hrthm.2012.01.020","article-title":"Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndrome","volume":"9","author":"Costa","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib784","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.hrthm.2010.09.011","article-title":"Trigger-specific risk factors and response to therapy in long QT syndrome type 2","volume":"7","author":"Kim","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib785","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.hrthm.2011.03.049","article-title":"Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome","volume":"8","author":"Migdalovich","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib786","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jacc.2005.09.056","article-title":"Effect of clinical phenotype on yield of long QT syndrome genetic testing","volume":"47","author":"Tester","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib787","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.hrthm.2012.01.026","article-title":"The phenomenon of \u201cQT stunning\u201d: The abnormal QT prolongation provoked by standing persists even as the heart rate returns to normal in patients with long QT syndrome","volume":"9","author":"Adler","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib788","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCEP.111.963330","article-title":"Genotype- and mutation site-specific QT adaptation during exercise, recovery, and postural changes in children with long-QT syndrome","volume":"4","author":"Aziz","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib789","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.hrthm.2010.03.006","article-title":"Utility of the recovery electrocardiogram after exercise: a novel indicator for the diagnosis and genotyping of long QT syndrome?","volume":"7","author":"Chattha","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib790","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/jce.12172","article-title":"Mutation location effect on severity of phenotype during exercise testing in type 1 long-QT syndrome: impact of transmembrane and C-loop location","volume":"24","author":"Laksman","year":"2013","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib791","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00246-010-9819-1","article-title":"Use of a cardioselective beta-blocker for pediatric patients with prolonged QT syndrome","volume":"32","author":"Moltedo","year":"2011","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib792","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1161\/CIRCULATIONAHA.111.028258","article-title":"Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands","volume":"124","author":"Sy","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib793","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ehj.2004.06.016","article-title":"Low incidence of cardiac events with beta-blocking therapy in children with long QT syndrome","volume":"25","author":"Villain","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib794","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.jacc.2009.12.015","article-title":"The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome","volume":"55","author":"Viskin","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib795","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/jama.292.11.1341","article-title":"Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers","volume":"292","author":"Priori","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib796","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jacc.2010.07.038","article-title":"Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals","volume":"57","author":"Goldenberg","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib797","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/01.CIR.96.7.2149","article-title":"Normalization of acquired QT prolongation in humans\u00a0by intravenous potassium","volume":"96","author":"Choy","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib798","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1124\/pr.110.003723","article-title":"Drug-induced long QT syndrome","volume":"62","author":"Kannankeril","year":"2010","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.hrthm.2017.10.036_bib799","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/jce.12739","article-title":"Long-QT syndrome and therapy for attention deficit\/hyperactivity disorder","volume":"26","author":"Zhang","year":"2015","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib800","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJMoa022147","article-title":"Risk stratification in the long-QT syndrome","volume":"348","author":"Priori","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib801","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCULATIONAHA.116.021823","article-title":"Clinical aspects of type 3 long-QT syndrome: an international multicenter study","volume":"134","author":"Wilde","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib802","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.hrthm.2008.10.017","article-title":"All LQT3 patients need an ICD: true or false?","volume":"6","author":"Schwartz","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib803","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1161\/01.CIR.87.6.1866","article-title":"The long QT syndrome in children. An international study of 287 patients","volume":"87","author":"Garson","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib804","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ehj.2003.12.019","article-title":"ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe","volume":"25","author":"Priori","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib805","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10840-016-0161-2","article-title":"Experience with bisoprolol in long-QT1 and long-QT2 syndrome","volume":"47","author":"Steinberg","year":"2016","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib806","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.jacc.2012.07.046","article-title":"Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol","volume":"60","author":"Chockalingam","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib807","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.hrthm.2004.01.006","article-title":"Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndrome","volume":"1","author":"Khositseth","year":"2004","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib808","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.CIR.97.5.451","article-title":"Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators","volume":"97","author":"Rashba","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib809","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1161\/01.CIR.100.24.2431","article-title":"Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing","volume":"100","author":"Dorostkar","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib810","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/0735-1097(92)90180-U","article-title":"Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome","volume":"20","author":"Eldar","year":"1992","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib811","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1161\/01.CIR.84.4.1524","article-title":"Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome","volume":"84","author":"Moss","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib812","doi-asserted-by":"crossref","first-page":"111k","DOI":"10.1016\/S0002-9149(00)01228-5","article-title":"Rate smoothing with cardiac pacing for preventing torsade de pointes","volume":"86","author":"Viskin","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib813","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1161\/CIRCEP.113.000102","article-title":"Left cardiac sympathetic denervation in long QT syndrome: analysis of therapeutic nonresponders","volume":"6","author":"Bos","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib814","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa0708006","article-title":"Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia","volume":"358","author":"Wilde","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib815","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.athoracsur.2008.07.100","article-title":"Video-assisted thoracoscopic left cardiac sympathetic denervation: a reliable minimally invasive approach for congenital long-QT syndrome","volume":"86","author":"Li","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.hrthm.2017.10.036_bib816","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1161\/CIRCULATIONAHA.115.015731","article-title":"Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac\u00a0sympathetic denervation","volume":"131","author":"De Ferrari","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib817","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00380-005-0820-1","article-title":"Surgical left cardiac sympathetic denervation for long QT syndrome: effects on QT interval and heart rate","volume":"20","author":"Li","year":"2005","journal-title":"Heart Vessels"},{"key":"10.1016\/j.hrthm.2017.10.036_bib818","first-page":"456","article-title":"Clinical and genetic features of Australian families with long QT syndrome: a registry\u2013based study","volume":"32","author":"Burns","year":"2016","journal-title":"J\u00a0Arrhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib819","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1161\/CIRCULATIONAHA.111.048041","article-title":"Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: implications for mutation-specific response to beta-blocker therapy in type 1 long-QT syndrome","volume":"125","author":"Barsheshet","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib820","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1161\/CIRCULATIONAHA.107.726950","article-title":"The common long-QT syndrome mutation KCNQ1\/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification","volume":"116","author":"Crotti","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib821","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/jce.12686","article-title":"Identification of low-risk adult congenital LQTS patients","volume":"26","author":"Zhang","year":"2015","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib822","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jacc.2004.02.034","article-title":"Short QT syndrome: pharmacological treatment","volume":"43","author":"Gaita","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib823","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jacc.2009.05.029","article-title":"Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy","volume":"54","author":"Spazzolini","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib824","unstructured":"Credible meds. Available at: http:\/\/www.crediblemeds.org. Accessed December 26,\u00a02016."},{"key":"10.1016\/j.hrthm.2017.10.036_bib825","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.hrthm.2015.04.043","article-title":"Stimulant therapy in children with attention-deficit\/hyperactivity disorder and concomitant long QT syndrome: a safe combination?","volume":"12","author":"Rohatgi","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib826","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF03091755","article-title":"Fever-triggered ventricular arrhythmias in Brugada syndrome and type 2 long-QT syndrome","volume":"18","author":"Amin","year":"2010","journal-title":"Neth Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib827","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"Roden","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib828","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.108.829267","article-title":"Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia","volume":"119","author":"Hayashi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib829","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCEP.114.002217","article-title":"Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry","volume":"8","author":"Roston","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib830","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.hrthm.2009.03.024","article-title":"Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery","volume":"6","author":"Collura","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib831","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jtcvs.2013.07.064","article-title":"Left thoracoscopic sympathectomy for cardiac denervation in patients with life-threatening ventricular arrhythmias","volume":"147","author":"Hofferberth","year":"2014","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.hrthm.2017.10.036_bib832","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00392-012-0492-7","article-title":"Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome","volume":"102","author":"Schneider","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib833","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.jacc.2011.01.026","article-title":"Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"57","author":"van der Werf","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib834","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.0000020013.73106.D8","article-title":"Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"106","author":"Priori","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib835","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.CIR.91.5.1512","article-title":"Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients","volume":"91","author":"Leenhardt","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib836","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.hrthm.2007.05.017","article-title":"Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia","volume":"4","author":"Rosso","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib837","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1540-8167.2005.40516.x","article-title":"Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations","volume":"16","author":"Swan","year":"2005","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib838","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.hrthm.2012.12.035","article-title":"Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia","volume":"10","author":"Watanabe","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib839","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/CIRCEP.110.959916","article-title":"Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia","volume":"4","author":"Hwang","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib840","doi-asserted-by":"crossref","first-page":"e003440","DOI":"10.1161\/CIRCEP.115.003440","article-title":"Patient outcomes from a specialized inherited arrhythmia clinic","volume":"9","author":"Adler","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib841","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.hrthm.2015.09.010","article-title":"Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications","volume":"13","author":"Olde Nordkamp","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib842","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.hrthm.2013.10.027","article-title":"Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia","volume":"11","author":"Roses-Noguer","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib843","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.hrthm.2011.01.048","article-title":"Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia","volume":"8","author":"Sy","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib844","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1161\/CIRCULATIONAHA.115.015731","article-title":"Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation","volume":"131","author":"De Ferrari","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib845","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa0708006","article-title":"Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia","volume":"358","author":"Wilde","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib846","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/jce.12739","article-title":"Long-QT syndrome and therapy for attention deficit\/hyperactivity disorder","volume":"26","author":"Zhang","year":"2015","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib847","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/CIRCGENETICS.113.000118","article-title":"New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia","volume":"6","author":"Jabbari","year":"2013","journal-title":"Circ Cardiovasc Genetics"},{"key":"10.1016\/j.hrthm.2017.10.036_bib848","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1161\/CIRCULATIONAHA.112.001216","article-title":"Calmodulin mutations associated with recurrent cardiac arrest in infants","volume":"127","author":"Crotti","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib849","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCGENETICS.113.000459","article-title":"Novel calmodulin mutations associated with congenital arrhythmia susceptibility","volume":"7","author":"Makita","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib850","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jacc.2013.07.091","article-title":"A\u00a0mutation in CALM1 encoding calmodulin in familial idiopathic ventricular fibrillation in childhood and adolescence","volume":"63","author":"Marsman","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib851","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ajhg.2012.08.015","article-title":"Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death","volume":"91","author":"Nyegaard","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib852","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/cge.12847","article-title":"Integration of 60,000 exomes and acmg guidelines question the role of catecholaminergic polymorphic ventricular tachycardia-associated variants","volume":"91","author":"Paludan-Muller","year":"2017","journal-title":"Clin Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib853","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jacc.2016.05.073","article-title":"Long-term trends in newly diagnosed Brugada syndrome: implications for risk stratification","volume":"68","author":"Casado-Arroyo","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib854","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1540-8167.2006.00455.x","article-title":"Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis","volume":"17","author":"Gehi","year":"2006","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib855","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jelectrocard.2013.04.003","article-title":"Prognosis and risk stratification of young adults with Brugada syndrome","volume":"46","author":"Hiraoka","year":"2013","journal-title":"J\u00a0Electrocardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib856","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jacc.2011.08.064","article-title":"Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry","volume":"59","author":"Priori","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib857","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.109.887026","article-title":"Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada syndrome registry","volume":"121","author":"Probst","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib858","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/CIRCULATIONAHA.115.017885","article-title":"Programmed ventricular stimulation for risk stratification in the Brugada syndrome: a pooled analysis","volume":"133","author":"Sroubek","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib859","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCEP.115.003109","article-title":"Management of Brugada syndrome: thirty-three-year experience using electrophysiologically guided therapy with class 1A antiarrhythmic drugs","volume":"8","author":"Belhassen","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib860","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1161\/CIRCEP.115.003220","article-title":"Brugada syndrome phenotype elimination by epicardial substrate ablation","volume":"8","author":"Brugada","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib861","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.110.972612","article-title":"Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium","volume":"123","author":"Nademanee","year":"2011","journal-title":"Circulation"},{"issue":"suppl 1","key":"10.1016\/j.hrthm.2017.10.036_bib862","first-page":"S10","article-title":"Endocardial mapping and catheter ablation for ventricular fibrillation prevention in Brugada syndrome","volume":"23","author":"Sunsaneewitayakul","year":"2012","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib863","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.hrthm.2016.07.025","article-title":"Characterization of the epicardial substrate for catheter ablation of Brugada syndrome","volume":"13","author":"Zhang","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib864","first-page":"665","article-title":"J-wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge","volume":"19","author":"Antzelevitch","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib865","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/eurheartj\/ehq381","article-title":"Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach","volume":"32","author":"Delise","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib866","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.hrthm.2014.03.022","article-title":"Procainamide infusion in the evaluation of unexplained cardiac arrest: from the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER)","volume":"11","author":"Somani","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib867","author":"Kusumoto","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib868","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1161\/CIRCEP.114.003044","article-title":"Asymptomatic Brugada syndrome: clinical characterization and long-term prognosis","volume":"8","author":"Sieira","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib869","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/CIRCEP.114.002647","article-title":"Prognostic value of programmed electrical stimulation in Brugada syndrome: 20 years experience","volume":"8","author":"Sieira","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib870","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jacc.2012.04.037","article-title":"Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing","volume":"60","author":"Crotti","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib871","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCGENETICS.109.853374","article-title":"SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome","volume":"2","author":"Probst","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib872","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/cge.12126","article-title":"High prevalence of genetic variants previously associated with Brugada syndrome in new exome data","volume":"84","author":"Risgaard","year":"2013","journal-title":"Clinical Genetics"},{"key":"10.1016\/j.hrthm.2017.10.036_bib873","unstructured":"Brugada drugs. Available at: http:\/\/www.brugadadrugs.org. Accessed October 6,\u00a02016."},{"key":"10.1016\/j.hrthm.2017.10.036_bib874","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.hrthm.2009.07.002","article-title":"Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org)","volume":"6","author":"Postema","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib875","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.hrthm.2016.02.013","article-title":"Impact of clinical and genetic findings on the management of young patients with Brugada syndrome","volume":"13","author":"Andorin","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib876","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib877","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011168.pub2","article-title":"Implantable defibrillators versus medical therapy for cardiac channelopathies","author":"McNamara","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hrthm.2017.10.036_bib878","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1161\/01.CIR.0000066319.56234.C8","article-title":"Defibrillator versus beta-blockers for unexplained death in Thailand (DEBUT): a randomized clinical trial","volume":"107","author":"Nademanee","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib879","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.hrthm.2015.10.038","article-title":"Monomorphic ventricular tachycardia in patients with Brugada syndrome: a multicenter retrospective study","volume":"13","author":"Rodriguez-Manero","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib880","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/01.CIR.101.5.510","article-title":"Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts","volume":"101","author":"Brugada","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib881","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1540-8167.2009.01490.x","article-title":"Usefulness of multichannel Holter ECG recording in the third intercostal space for detecting type 1 Brugada ECG: comparison with repeated 12-lead ECGs","volume":"20","author":"Shimeno","year":"2009","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib882","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jacc.2014.12.031","article-title":"Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience","volume":"65","author":"Conte","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib883","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.hrthm.2009.09.069","article-title":"An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing","volume":"7","author":"Kapplinger","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib884","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.hrthm.2015.08.038","article-title":"Risk stratification in Brugada syndrome: clinical characteristics, electrocardiographic parameters, and auxiliary testing","volume":"13","author":"Adler","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib885","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1161\/hc1102.105288","article-title":"Natural history of Brugada syndrome: insights for risk stratification and management","volume":"105","author":"Priori","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib886","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jacc.2008.07.010","article-title":"J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance","volume":"52","author":"Rosso","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib887","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.amjcard.2011.07.055","article-title":"Natural history of the electrocardiographic pattern of early repolarization in ambulatory patients","volume":"108","author":"Adhikarla","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib888","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jacc.2008.10.044","article-title":"Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy","volume":"53","author":"Haissaguerre","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib889","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/europace\/euv301","article-title":"Early repolarization pattern is the strongest predictor of arrhythmia recurrence in patients with idiopathic ventricular fibrillation: results from a single centre long-term follow-up over 20 years","volume":"18","author":"Siebermair","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib890","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.hrthm.2012.06.008","article-title":"A\u00a0meta-analysis of genome-wide association studies of the electrocardiographic early repolarization pattern","volume":"9","author":"Sinner","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib891","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1056\/NEJMoa0907589","article-title":"Long-term outcome associated with early repolarization on electrocardiography","volume":"361","author":"Tikkanen","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib892","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/CIRCEP.112.970863","article-title":"Association of early repolarization and sudden cardiac death during an acute coronary event","volume":"5","author":"Tikkanen","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib893","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.hrthm.2014.05.024","article-title":"Early repolarization as a predictor of arrhythmic and nonarrhythmic cardiac events in middle-aged subjects","volume":"11","author":"Junttila","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib894","doi-asserted-by":"crossref","first-page":"e003375","DOI":"10.1161\/JAHA.116.003375","article-title":"Role of early repolarization pattern in increasing risk of death","volume":"5","author":"Cheng","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2017.10.036_bib895","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/bjsports-2015-094827","article-title":"The prevalence and significance of a short QT interval in 18,825\u00a0low-risk individuals including athletes","volume":"50","author":"Dhutia","year":"2016","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib896","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jacc.2010.09.048","article-title":"The short QT syndrome: proposed diagnostic criteria","volume":"57","author":"Gollob","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib897","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2011.03.038","article-title":"Long-term follow-up of patients with short QT syndrome","volume":"58","author":"Giustetto","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib898","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jacc.2013.09.078","article-title":"Novel insight into the natural history of short QT syndrome","volume":"63","author":"Mazzanti","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib899","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.jacc.2012.12.025","article-title":"Long-term follow-up of a pediatric cohort with short QT syndrome","volume":"61","author":"Villafane","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib900","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/eurheartj\/ehl185","article-title":"Short QT syndrome: clinical findings and diagnostic-therapeutic implications","volume":"27","author":"Giustetto","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib901","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1540-8167.2012.02295.x","article-title":"Electrical storm in short-QT syndrome successfully treated with isoproterenol","volume":"23","author":"Bun","year":"2012","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib902","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1161\/CIRCEP.115.003256","article-title":"Short QT interval prevalence and clinical outcomes in a pediatric population","volume":"8","author":"Guerrier","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib903","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/anec.12157","article-title":"Short QT in a cohort of 1.7 million persons: prevalence, correlates, and prognosis","volume":"19","author":"Iribarren","year":"2014","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib904","first-page":"232","article-title":"Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society\/Canadian Heart Rhythm Society joint position paper","volume":"27","author":"Gollob","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib905","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/0002-8703(93)90664-U","article-title":"Verapamil for the suppression of idiopathic ventricular tachycardia of left bundle branch block-like morphology","volume":"126","author":"Gill","year":"1993","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib906","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1111\/j.1540-8159.1992.tb03033.x","article-title":"Comparison of verapamil and diltiazem in the suppression of idiopathic ventricular tachycardia","volume":"15","author":"Gill","year":"1992","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib907","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ahj.2011.01.006","article-title":"Treatment and outcomes in patients with myocardial infarction treated with acute beta\u2013blocker therapy: results from the American College of Cardiology\u2019s NCDR(R)","volume":"161","author":"Kontos","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib908","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0735-1097(95)00427-0","article-title":"Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group","volume":"27","author":"Levine","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib909","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2005.05.077","article-title":"Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract","volume":"46","author":"Noda","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib910","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4070\/kcj.2016.0303","article-title":"Idiopathic polymorphic ventricular tachycardia: a \u201cbenign disease\u201d with a touch of bad luck?","volume":"47","author":"Viskin","year":"2017","journal-title":"Korean Circ J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib911","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1540-8167.2005.50040.x","article-title":"The \u201cshort-coupled\u201d variant of right ventricular outflow ventricular tachycardia: a not-so-benign form of benign ventricular tachycardia?","volume":"16","author":"Viskin","year":"2005","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib912","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1067\/mhj.2002.125516","article-title":"Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebo-controlled study","volume":"144","author":"Krittayaphong","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib913","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCEP.113.000805","article-title":"Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract: prospective randomized study","volume":"7","author":"Ling","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib914","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/01.CIR.92.6.1517","article-title":"Efficacy and safety of d-sotalol, a pure class III antiarrhythmic compound, in patients with symptomatic complex ventricular ectopy. Results of a multicenter, randomized, double-blind, placebo-controlled dose-finding study. The d-Sotalol PVC Study Group","volume":"92","author":"Hohnloser","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib915","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cpcardiol.2006.10.002","article-title":"Idiopathic ventricular tachycardia: diagnosis and management","volume":"32","author":"Badhwar","year":"2007","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib916","doi-asserted-by":"crossref","first-page":"90R","DOI":"10.1016\/S0002-9149(99)00708-0","article-title":"Meta-analysis of antiarrhythmic drug trials","volume":"84","author":"Connolly","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib917","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jacc.2004.12.025","article-title":"Idiopathic ventricular arrhythmia arising from the mitral annulus: a distinct subgroup of idiopathic ventricular arrhythmias","volume":"45","author":"Tada","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib918","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1161\/CIRCEP.108.795948","article-title":"The left ventricular ostium: an anatomic concept relevant to idiopathic ventricular arrhythmias","volume":"1","author":"Yamada","year":"2008","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib919","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/CIRCEP.114.002259","article-title":"Radiofrequency catheter ablation of idiopathic ventricular arrhythmias originating from intramural foci in the left ventricular outflow tract: efficacy of sequential versus simultaneous unipolar catheter ablation","volume":"8","author":"Yamada","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib920","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCEP.113.000805","article-title":"Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract: prospective randomized study","volume":"7","author":"Ling","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib921","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.hrthm.2013.10.055","article-title":"Ventricular premature depolarization QRS duration as a new marker of risk for the development of ventricular premature depolarization-induced cardiomyopathy","volume":"11","author":"Carballeira Pol","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib922","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00392-015-0817-4","article-title":"Electrophysiological and electrocardiographic predictors of ventricular arrhythmias originating from the left ventricular outflow tract within and below the coronary sinus cusps","volume":"104","author":"Kamioka","year":"2015","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib923","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/europace\/euq510","article-title":"Catheter ablation of right ventricular outflow tract tachycardia: a simplified remote-controlled approach","volume":"13","author":"Konstantinidou","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib924","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jacep.2015.04.005","article-title":"Multicenter outcomes for catheter ablation of idiopathic premature ventricular complexes","volume":"1","author":"Latchamsetty","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib925","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/j.jacc.2015.09.094","article-title":"Idiopathic ventricular arrhythmias originating from the pulmonary sinus cusp: prevalence, electrocardiographic\/electrophysiological characteristics, and catheter ablation","volume":"66","author":"Liao","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib926","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1161\/01.CIR.82.6.2093","article-title":"Long-term results of catheter ablation of idiopathic right ventricular tachycardia","volume":"82","author":"Morady","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib927","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0735-1097(01)01767-3","article-title":"Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation","volume":"39","author":"Ouyang","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib928","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1016\/j.hrthm.2014.07.024","article-title":"EHRA\/HRS\/APHRS expert consensus on ventricular arrhythmias","volume":"11","author":"Pedersen","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib929","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.hrthm.2007.12.021","article-title":"Idiopathic ventricular arrhythmias arising from the pulmonary artery: prevalence, characteristics, and topography of the arrhythmia origin","volume":"5","author":"Tada","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib930","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jacc.2008.03.040","article-title":"Idiopathic ventricular arrhythmias originating from the aortic root prevalence, electrocardiographic and electrophysiologic characteristics, and results of radiofrequency catheter ablation","volume":"52","author":"Yamada","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib931","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1161\/CIRCEP.110.939744","article-title":"Idiopathic ventricular arrhythmias originating from the left ventricular summit: anatomic concepts relevant to ablation","volume":"3","author":"Yamada","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib932","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1540-8167.2009.01608.x","article-title":"Idiopathic left ventricular arrhythmias originating adjacent to the left aortic sinus of valsalva: electrophysiological rationale for the surface electrocardiogram","volume":"21","author":"Yamada","year":"2010","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib933","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.hrthm.2015.03.009","article-title":"Ventricular arrhythmias from the coronary venous system: prevalence, mapping, and ablation","volume":"12","author":"Mountantonakis","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib934","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/CIRCEP.114.001615","article-title":"Ventricular arrhythmias near the distal great cardiac vein: challenging arrhythmia for ablation","volume":"7","author":"Nagashima","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib935","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/jce.12587","article-title":"Electrophysiologic characteristics of ventricular arrhythmias arising from the aortic mitral continuity-potential role of the conduction system","volume":"26","author":"Hai","year":"2015","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib936","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.hrthm.2006.09.025","article-title":"Idiopathic ventricular arrhythmias originating from the tricuspid annulus: prevalence, electrocardiographic characteristics, and results of radiofrequency catheter ablation","volume":"4","author":"Tada","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib937","doi-asserted-by":"crossref","first-page":"811","DOI":"10.4070\/kcj.2013.43.12.811","article-title":"Electrophysiological characteristics related to outcome after catheter ablation of idiopathic ventricular arrhythmia originating from the papillary muscle in the left ventricle","volume":"43","author":"Ban","year":"2013","journal-title":"Korean Circ J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib938","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.hrthm.2010.01.040","article-title":"Ventricular arrhythmias originating from papillary muscles in the right ventricle","volume":"7","author":"Crawford","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib939","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/CIRCEP.107.742940","article-title":"Ventricular tachycardia originating from the posterior papillary muscle in the left ventricle: a distinct clinical syndrome","volume":"1","author":"Doppalapudi","year":"2008","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib940","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCEP.109.922310","article-title":"Electrocardiographic and electrophysiological characteristics in idiopathic ventricular arrhythmias originating from the papillary muscles in the left ventricle: relevance for catheter ablation","volume":"3","author":"Yamada","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib941","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.hrthm.2010.07.013","article-title":"Predictors of successful catheter ablation of ventricular arrhythmias arising from the papillary muscles","volume":"7","author":"Yokokawa","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib942","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.hrthm.2005.06.009","article-title":"Idiopathic fascicular left ventricular tachycardia: linear ablation lesion strategy for noninducible or nonsustained tachycardia","volume":"2","author":"Lin","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib943","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1161\/CIRCEP.115.003080","article-title":"Catheter ablation of fascicular ventricular tachycardia: long-term clinical outcomes and mechanisms of recurrence","volume":"8","author":"Liu","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib944","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0735-1097(00)00780-4","article-title":"Demonstration of diastolic and presystolic Purkinje potentials as critical potentials in a macroreentry circuit of verapamil-sensitive idiopathic left ventricular tachycardia","volume":"36","author":"Nogami","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib945","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/hrt.46.6.679","article-title":"Response of recurrent sustained ventricular tachycardia to verapamil","volume":"46","author":"Belhassen","year":"1981","journal-title":"Br Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib946","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/0002-9149(83)90574-X","article-title":"Ventricular tachycardia induced by atrial stimulation in patients without symptomatic cardiac disease","volume":"52","author":"German","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib947","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0735-1097(01)01117-2","article-title":"Effects of verapamil and lidocaine on two components of the re-entry circuit of verapamil-senstitive idiopathic left ventricular tachycardia","volume":"37","author":"Tsuchiya","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib948","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/CIRCGENETICS.115.001370","article-title":"Whole-exome molecular autopsy after exertion-related sudden unexplained death in the young","volume":"9","author":"Anderson","year":"2016","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib949","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.CIR.77.3.560","article-title":"Idiopathic sustained left ventricular tachycardia: clinical and electrophysiologic characteristics","volume":"77","author":"Ohe","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib950","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1747-0803.2006.00020.x","article-title":"Verapamil-sensitive ventricular tachycardia in an infant","volume":"1","author":"Snyder","year":"2006","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.hrthm.2017.10.036_bib951","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1536\/jhj.44.667","article-title":"Verapamil sensitive idiopathic ventricular tachycardia in an infant","volume":"44","author":"Wang","year":"2003","journal-title":"Jpn Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib952","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/CIRCGENETICS.115.001370","article-title":"Whole-exome molecular autopsy after exertion-related sudden unexplained death in the young","volume":"9","author":"Anderson","year":"2016","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib953","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2016.06.088","article-title":"Clinical presentation of pediatric patients at risk for sudden cardiac arrest","author":"Dalal","year":"2016","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.hrthm.2017.10.036_bib954","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.hrthm.2013.08.022","article-title":"Familial cardiological and targeted genetic evaluation: low yield in sudden unexplained death and high yield in unexplained cardiac arrest syndromes","volume":"10","author":"Kumar","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib955","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0002-9149(90)90591-N","article-title":"Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope","volume":"66","author":"Linzer","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib956","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1056\/NEJMoa043938","article-title":"Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both","volume":"352","author":"Solomon","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib957","doi-asserted-by":"crossref","first-page":"941","DOI":"10.4065\/mcp.2011.0373","article-title":"Unexplained drownings and the cardiac channelopathies: a molecular autopsy series","volume":"86","author":"Tester","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hrthm.2017.10.036_bib958","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00414-016-1424-2","article-title":"The role of known variants of KCNQ1, KCNH2, KCNE1, SCN5A, and NOS1AP in water-related deaths","author":"Tzimas","year":"2016","journal-title":"Int J Legal Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib959","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.forsciint.2014.01.014","article-title":"Cardiac channelopathy testing in 274 ethnically diverse sudden unexplained deaths","volume":"237","author":"Wang","year":"2014","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.hrthm.2017.10.036_bib960","first-page":"259","article-title":"True idiopathic ventricular fibrillation in out-of-hospital cardiac arrest survivors in the Swiss Canton Ticino: prevalence, clinical features, and long-term follow-up","volume":"19","author":"Conte","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib961","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10840-016-0143-4","article-title":"Long-time \u201creal-life\u201d performance of the subcutaneous ICD in patients with electrical heart disease or idiopathic ventricular fibrillation","volume":"47","author":"Frommeyer","year":"2016","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib962","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/01.CIR.0000027564.55739.B1","article-title":"Mapping and ablation of idiopathic ventricular fibrillation","volume":"106","author":"Ha\u00efssaguerre","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib963","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jacc.2009.03.065","article-title":"Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study","volume":"54","author":"Knecht","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib964","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1161\/01.CIR.89.1.206","article-title":"Short-coupled variant of torsade de pointes. A new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias","volume":"89","author":"Leenhardt","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib965","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0140-6736(02)07807-8","article-title":"Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation","volume":"359","author":"Ha\u00efssaguerre","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib966","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/adc.2009.178152","article-title":"Presentation and outcome of water-related events in children with long QT syndrome","volume":"96","author":"Albertella","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.hrthm.2017.10.036_bib967","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1017\/S1047951115001481","article-title":"Risk of cardiac disease and observations on lack of potential predictors by clinical history among children presenting for cardiac evaluation of mid-exertional syncope","volume":"26","author":"Miyake","year":"2016","journal-title":"Cardiol Young"},{"key":"10.1016\/j.hrthm.2017.10.036_bib968","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.ahj.2008.08.007","article-title":"Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)","volume":"156","author":"Gula","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib969","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.hrthm.2015.03.013","article-title":"The role of the sodium current complex in a nonreferred nationwide cohort of sudden infant death syndrome","volume":"12","author":"Winkel","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib970","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2005.05.077","article-title":"Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract","volume":"46","author":"Noda","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib971","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.hrthm.2014.08.029","article-title":"Idiopathic ventricular arrhythmias originating from the moderator band: electrocardiographic characteristics and treatment by catheter ablation","volume":"12","author":"Sadek","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib972","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.hrthm.2013.12.030","article-title":"Catheter ablation of ventricular fibrillation: importance of left ventricular outflow tract and papillary muscle triggers","volume":"11","author":"Van","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib973","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0002-8703(90)90025-S","article-title":"Idiopathic ventricular fibrillation","volume":"120","author":"Viskin","year":"1990","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib974","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0140-6736(02)07807-8","article-title":"Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation","volume":"359","author":"Ha\u00efssaguerre","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib975","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/01.CIR.0000027564.55739.B1","article-title":"Mapping and ablation of idiopathic ventricular fibrillation","volume":"106","author":"Ha\u00efssaguerre","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib976","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCEP.111.963348","article-title":"Premature ventricular contraction-induced cardiomyopathy: a treatable condition","volume":"5","author":"Lee","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib977","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199507133330201","article-title":"Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure","volume":"333","author":"Singh","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib978","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.hrthm.2010.03.036","article-title":"Relationship between burden of premature ventricular complexes and left ventricular function","volume":"7","author":"Baman","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib979","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/europace\/eus371","article-title":"Electrocardiographic and electrophysiological characteristics of premature ventricular complexes associated with left ventricular dysfunction in patients without structural heart disease","volume":"15","author":"Ban","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib980","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.hrthm.2007.03.003","article-title":"Radiofrequency ablation of frequent, idiopathic premature ventricular complexes: comparison with a control group without intervention","volume":"4","author":"Bogun","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib981","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.hrthm.2013.10.055","article-title":"Ventricular premature depolarization QRS duration as a new marker of risk for the development of ventricular premature depolarization-induced cardiomyopathy","volume":"11","author":"Carballeira Pol","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib982","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1540-8167.2011.02021.x","article-title":"Characteristics of premature ventricular complexes as correlates of reduced left ventricular systolic function: study of the burden, duration, coupling interval, morphology and site of origin of PVCs","volume":"22","author":"Del Carpio Munoz","year":"2011","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib983","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.hrthm.2012.05.019","article-title":"Predictors of recovery of left ventricular dysfunction after ablation of frequent ventricular premature depolarizations","volume":"9","author":"Deyell","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib984","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/jce.12967","article-title":"A\u00a0new combined parameter to predict premature ventricular complexes induced cardiomyopathy: impact and recognition of epicardial origin","volume":"27","author":"Hamon","year":"2016","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib985","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1540-8167.2010.01986.x","article-title":"Tachycardia-induced cardiomyopathy in patients with idiopathic ventricular arrhythmias: the incidence, clinical and electrophysiologic characteristics, and the predictors","volume":"22","author":"Hasdemir","year":"2011","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib986","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1542-474X.2007.00204.x","article-title":"Frequent premature ventricular complexes originating from the right ventricular outflow tract are associated with left ventricular dysfunction","volume":"13","author":"Kanei","year":"2008","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib987","doi-asserted-by":"crossref","DOI":"10.1111\/jce.12391","article-title":"Coupling interval dispersion and body mass index are independent predictors of idiopathic premature ventricular complex-induced cardiomyopathy","volume":"25","author":"Kawamura","year":"2014","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib988","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1136\/hrt.2008.159558","article-title":"Prognostic significance of frequent premature ventricular contractions originating from the ventricular outflow tract in patients with normal left ventricular function","volume":"95","author":"Niwano","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2017.10.036_bib989","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.hrthm.2011.02.034","article-title":"The role of interpolation in PVC-induced cardiomyopathy","volume":"8","author":"Olgun","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib990","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.hrthm.2012.10.011","article-title":"Recovery from left ventricular dysfunction after ablation of frequent premature ventricular complexes","volume":"10","author":"Yokokawa","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib991","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.hrthm.2013.10.033","article-title":"Relative efficacy of catheter ablation vs antiarrhythmic drugs in treating premature ventricular contractions: a single-center retrospective study","volume":"11","author":"Zhong","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib992","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.hrthm.2012.05.019","article-title":"Predictors of recovery of left ventricular dysfunction after ablation of frequent ventricular premature depolarizations","volume":"9","author":"Deyell","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib993","first-page":"355","article-title":"Randomized double blind trial comparing sotalol and propranolol in chronic ventricular arrhythmia","volume":"4","author":"Kubac","year":"1988","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib994","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1161\/CIR.0000000000000245","article-title":"Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 9: arrhythmias and conduction defects: a scientific statement from the American Heart Association and American College of Cardiology","volume":"132","author":"Zipes","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib995","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0735-1097(02)01977-0","article-title":"Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes","volume":"40","author":"Biffi","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib996","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.hrthm.2014.09.009","article-title":"Clinical significance of exercise-induced ventricular tachyarrhythmias in trained athletes without cardiovascular abnormalities","volume":"12","author":"Verdile","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib997","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCULATIONAHA.115.015431","article-title":"Incidence, cause, and comparative frequency of sudden cardiac death in national collegiate athletic association athletes: a decade in review","volume":"132","author":"Harmon","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib998","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.hrthm.2012.11.024","article-title":"Incidence of cardiovascular sudden deaths in Minnesota high school athletes","volume":"10","author":"Maron","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib999","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/bjsports-2014-093872","article-title":"Incidence of sudden cardiac death in athletes: a state-of-the-art review","volume":"48","author":"Harmon","year":"2014","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1000","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1161\/CIRCULATIONAHA.110.008979","article-title":"Sports-related sudden death in the general population","volume":"124","author":"Marijon","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1001","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/CIRCULATIONAHA.111.076810","article-title":"Incidence, causes, and survival trends from cardiovascular-related sudden cardiac arrest in children and young adults 0 to 35 years of age: a 30-year review","volume":"126","author":"Meyer","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1002","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jama.2013.8711","article-title":"Incidence of sports-related sudden death in France by specific sports and sex","volume":"310","author":"Marijon","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1003","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/CIRCGENETICS.115.001370","article-title":"Whole-exome molecular autopsy after exertion-related sudden unexplained death in the young","volume":"9","author":"Anderson","year":"2016","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1004","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa1510687","article-title":"A\u00a0prospective study of sudden cardiac death among children and young adults","volume":"374","author":"Bagnall","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1005","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/eurheartj\/ehv063","article-title":"Sudden cardiac death in the young: the molecular autopsy and a practical approach to surviving relatives","volume":"36","author":"Semsarian","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1006","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.amjmed.2016.02.031","article-title":"Demographics and epidemiology of sudden deaths in young competitive athletes: from the United States national registry","volume":"129","author":"Maron","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1007","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jacc.2014.05.025","article-title":"Life-threatening events during endurance sports: is heat stroke more prevalent than arrhythmic death?","volume":"64","author":"Yankelson","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1008","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.jacc.2014.01.041","article-title":"Incidence and causes of sudden death in U.S. college athletes","volume":"63","author":"Maron","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1009","first-page":"e334","volume":"132","author":"Link","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1010","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.jtcvs.2016.06.066","article-title":"Expert consensus guideline: anomalous aortic origin of a coronary artery \u2013 American Association for Thoracic Surgery Clinical Practice Guidelines","volume":"153","author":"Brothers","year":"2017","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1011","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1161\/CIR.0000000000000240","article-title":"Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 4: congenital heart disease: a scientific statement from the American Heart Association and American College of Cardiology","volume":"132","author":"Van Hare","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1012","doi-asserted-by":"crossref","first-page":"e326","DOI":"10.1161\/CIR.0000000000000246","article-title":"Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 10: the cardiac channelopathies: a scientific statement from the American Heart Association and American College of Cardiology","volume":"132","author":"Ackerman","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1013","first-page":"e273","volume":"132","author":"Maron","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1014","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jacc.2006.09.054","article-title":"Long QT syndrome and pregnancy","volume":"49","author":"Seth","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1015","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIR.0000000000000300","article-title":"Cardiac arrest in pregnancy: a scientific statement from the American Heart Association","volume":"132","author":"Jeejeebhoy","year":"2015","journal-title":"Circulation"},{"issue":"suppl 3","key":"10.1016\/j.hrthm.2017.10.036_bib1016","first-page":"S829","article-title":"Part 12: cardiac arrest in special situations: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care","volume":"122","author":"Vanden Hoek","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1017","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1161\/01.CIR.96.9.2808","article-title":"Implantable cardioverter-defibrillators and pregnancy: a safe combination?","volume":"96","author":"Natale","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1018","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2214\/AJR.12.9864","article-title":"Cardiovascular imaging of the pregnant patient","volume":"200","author":"Colletti","year":"2013","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1019","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.hrthm.2004.01.006","article-title":"Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndrome","volume":"1","author":"Khositseth","year":"2004","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.CIR.97.5.451","article-title":"Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators","volume":"97","author":"Rashba","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1021","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jacc.2006.05.060","article-title":"Does pregnancy increase cardiac risk for LQT1 patients with the KCNQ1-A341V mutation?","volume":"48","author":"Heradien","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1022","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/pds.2068","article-title":"Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy","volume":"20","author":"Davis","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1023","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijcard.2014.09.013","article-title":"Cardiac medication during pregnancy, data from the ROPAC","volume":"177","author":"Ruys","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1024","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1067\/mob.2001.117973","article-title":"Fetal sinus bradycardia and the long QT syndrome","volume":"185","author":"Beinder","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/hrt.77.3.198","article-title":"Prenatal findings in patients with prolonged QT interval in the neonatal period","volume":"77","author":"Hofbeck","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1026","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/CIRCEP.113.000618","article-title":"Arrhythmia phenotype during fetal life suggests long-QT syndrome genotype: risk stratification of perinatal long-QT syndrome","volume":"6","author":"Cuneo","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1027","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jelectrocard.2016.07.023","article-title":"The natural history of fetal long QT syndrome","volume":"49","author":"Cuneo","year":"2016","journal-title":"J\u00a0Electrocardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1028","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/hc5790.094909","article-title":"Conceptus radiation dose and risk from cardiac catheter ablation procedures","volume":"104","author":"Damilakis","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1029","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/ejhf.188","article-title":"Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter\/defibrillator","volume":"16","author":"Duncker","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1030","author":"Kusumoto","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1031","first-page":"E1","article-title":"Guiding principles for the care of older adults with multimorbidity: an approach for clinicians","volume":"60","year":"2012","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1032","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1033","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","article-title":"A\u00a0randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators","volume":"341","author":"Buxton","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1034","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators","volume":"335","author":"Moss","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1035","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1036","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.ajkd.2013.12.009","article-title":"Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials","volume":"64","author":"Pun","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1037","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/j.ajkd.2011.03.026","article-title":"Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States","volume":"58","author":"Charytan","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1038","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jacc.2014.12.049","article-title":"Bradycardia and asystole is the predominant mechanism of sudden cardiac death in patients with chronic kidney disease","volume":"65","author":"Wong","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1039","author":"Kusumoto","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1040","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/ndt\/gfu274","article-title":"Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study","volume":"30","author":"Pun","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1041","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.jacc.2014.02.536","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1042","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2016.02.057","article-title":"Natural history, diagnostic approaches, and therapeutic strategies for patients with asymptomatic severe aortic stenosis","volume":"67","author":"Genereux","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1043","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.CIR.0000028933.34260.09","article-title":"Natural history of asymptomatic mitral valve prolapse in the community","volume":"106","author":"Avierinos","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1044","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/S0735-1097(99)00474-X","article-title":"Sudden death in mitral regurgitation due to flail leaflet","volume":"34","author":"Grigioni","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1045","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/jce.12914","article-title":"Bileaflet mitral valve prolapse and risk of ventricular dysrhythmias and death","volume":"27","author":"Nordhues","year":"2016","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1046","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/CIRCULATIONAHA.115.016291","article-title":"Arrhythmic mitral valve prolapse and sudden cardiac death","volume":"132","author":"Basso","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1047","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jacc.2013.02.060","article-title":"Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic out-of-hospital cardiac arrest","volume":"62","author":"Sriram","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1048","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1161\/01.CIR.0000065223.21530.11","article-title":"Prospective study of sudden cardiac death among women in the United States","volume":"107","author":"Albert","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1049","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1053\/hj.1998.v136.90226","article-title":"Sudden coronary death in women","volume":"136","author":"Kannel","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1050","doi-asserted-by":"crossref","first-page":"e002398","DOI":"10.1161\/JAHA.115.002398","article-title":"Lifetime risk for sudden cardiac death in the community","volume":"5","author":"Bogle","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1051","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1161\/hc4701.099784","article-title":"Out-of-hospital cardiac arrest in men and women","volume":"104","author":"Kim","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1052","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10840-012-9669-2","article-title":"Survival advantage from ventricular fibrillation and pulseless electrical activity in women compared to men: the Oregon Sudden Unexpected Death Study","volume":"34","author":"Teodorescu","year":"2012","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1053","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.resuscitation.2014.06.008","article-title":"Survival after out-of-hospital cardiac arrest in relation to sex: a nationwide registry-based study","volume":"85","author":"Wissenberg","year":"2014","journal-title":"Resuscitation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1054","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.resuscitation.2012.12.004","article-title":"Exploring gender differences and the \u201coestrogen effect\u201d in an Australian out-of-hospital cardiac arrest population","volume":"84","author":"Bray","year":"2013","journal-title":"Resuscitation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1055","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.resuscitation.2016.03.002","article-title":"Associations between gender and cardiac arrest outcomes in Pan-Asian out-of-hospital cardiac arrest patients","volume":"102","author":"Ng","year":"2016","journal-title":"Resuscitation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1056","first-page":"121","article-title":"Resuscitation outcomes of reproductive-age females who experienced out-of-hospital cardiac arrest","volume":"6","author":"Hagihara","year":"2017","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1057","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/acem.12540","article-title":"Differential survival for men and women from out-of-hospital cardiac arrest varies by age: results from the OPALS study","volume":"21","author":"Safdar","year":"2014","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1058","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/01.CIR.93.6.1170","article-title":"Sex differences in cardiac arrest survivors","volume":"93","author":"Albert","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1059","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.jacc.2009.07.038","article-title":"Women have a lower prevalence of structural heart disease as a precursor to sudden cardiac arrest: The Ore-SUDS (Oregon Sudden Unexpected Death Study)","volume":"54","author":"Chugh","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1060","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.resuscitation.2014.09.018","article-title":"Neurological prognostication by gender in out-of-hospital cardiac arrest patients receiving hypothermia treatment","volume":"85","author":"Kim","year":"2014","journal-title":"Resuscitation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1061","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jama.2013.8711","article-title":"Incidence of sports-related sudden death in France by specific sports and sex","volume":"310","author":"Marijon","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1062","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1001\/jama.1993.03510210076031","article-title":"Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs","volume":"270","author":"Makkar","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1063","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.amjcard.2015.09.042","article-title":"Influence of gender on the tolerability, safety, and efficacy of quinidine used for treatment of supraventricular and ventricular arrhythmias","volume":"116","author":"Higgins","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1064","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1253\/circj.CJ-10-0941","article-title":"Gender and age differences in candidates for radiofrequency catheter ablation of idiopathic ventricular arrhythmias","volume":"75","author":"Tanaka","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1065","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1161\/01.CIR.81.6.1744","article-title":"Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study","volume":"81","author":"Antman","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1066","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3109\/15563650.2014.943907","article-title":"Digoxin-specific antibody fragments in the treatment of digoxin toxicity","volume":"52","author":"Chan","year":"2014","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1067","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/01.CIR.64.6.1167","article-title":"Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients","volume":"64","author":"Keren","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1068","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.CIR.77.2.392","article-title":"Treatment of torsade de pointes with magnesium sulfate","volume":"77","author":"Tzivoni","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1069","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1124\/pr.110.003723","article-title":"Drug-induced long QT syndrome","volume":"62","author":"Kannankeril","year":"2010","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1070","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/01.CIR.96.7.2149","article-title":"Normalization of acquired QT prolongation in humans by intravenous potassium","volume":"96","author":"Choy","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1071","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/01.CIR.93.3.407","article-title":"Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence","volume":"93","author":"Yang","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1072","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1540-8159.1983.tb04410.x","article-title":"Effect of the antiarrhythmic agent flecainide acetate on acute and chronic pacing thresholds","volume":"6","author":"Hellestrand","year":"1983","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1073","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/01.CIR.79.5.1106","article-title":"Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation","volume":"79","author":"Echt","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1074","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jacc.2015.12.063","article-title":"Predicting the unpredictable: drug-induced QT prolongation and torsades de pointes","volume":"67","author":"Schwartz","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1075","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1161\/01.CIR.99.9.1265","article-title":"Digitalis","volume":"99","author":"Hauptman","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1076","doi-asserted-by":"crossref","first-page":"108G","DOI":"10.1016\/0002-9149(92)91259-7","article-title":"Recognition and management of digitalis toxicity","volume":"69","author":"Kelly","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1077","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1540-8159.2012.03410.x","article-title":"Management of patients with drug-induced atrioventricular block","volume":"35","author":"Osmonov","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1078","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1016\/j.jacc.2006.07.010","volume":"48","author":"Zipes","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1079","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078511","article-title":"Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizes","volume":"8","author":"Behr","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCGENETICS.111.960930","article-title":"A\u00a0large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes","volume":"5","author":"Kaab","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1081","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1161\/CIRCULATIONAHA.116.023980","article-title":"A\u00a0common genetic variant risk score is associated with drug-induced QT prolongation and torsade de pointes risk: a pilot study","volume":"135","author":"Strauss","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1082","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1161\/01.CIR.0000014448.19052.4C","article-title":"Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes","volume":"105","author":"Yang","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1083","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jacc.2014.01.031","article-title":"Exome sequencing implicates an increased burden of rare potassium channel variants in the risk of drug-induced long QT interval syndrome","volume":"63","author":"Weeke","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1084","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1085","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S0140-6736(80)92395-8","article-title":"Oral mexiletine in high-risk patients after myocardial infarction","volume":"2","author":"Chamberlain","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1086","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/pgmj.60.700.98","article-title":"Oral disopyramide after admission to hospital with suspected acute myocardial infarction. U. K. Rythmodan Multicentre Study Group","volume":"60","year":"1984","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1087","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/0002-9149(88)90282-2","article-title":"Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment","volume":"62","author":"Crijns","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1088","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1161\/01.CIR.99.5.666","article-title":"\u201cBrugada\u201d syndrome: clinical data and suggested pathophysiological mechanism","volume":"99","author":"Alings","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1089","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.hrthm.2016.03.016","article-title":"Drug-induced Brugada syndrome: clinical characteristics and risk factors","volume":"13","author":"Konigstein","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1090","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1540-8167.2001.00275.x","article-title":"Brugada syndrome mimicked by tricyclic antidepressant overdose","volume":"12","author":"Tada","year":"2001","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1091","doi-asserted-by":"crossref","first-page":"845","DOI":"10.4065\/75.8.845","article-title":"Brugada-type electrocardiographic pattern induced by cocaine","volume":"75","author":"Littmann","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1092","unstructured":"Brugada drugs. Available at: http:\/\/www.brugadadrugs.org. Accessed October 6,\u00a02016."},{"key":"10.1016\/j.hrthm.2017.10.036_bib1093","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/01.CIR.80.4.994","article-title":"Acute electrophysiologic effects of sodium administration in dogs treated with O-desmethyl encainide","volume":"80","author":"Bajaj","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1094","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1161\/01.CIR.80.6.1571","article-title":"Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol","volume":"80","author":"Myerburg","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1095","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.ajem.2015.04.012","article-title":"Life-threatening flecainide overdose treated with intralipid and extracorporeal membrane oxygenation","volume":"33","author":"Brumfield","year":"2015","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1096","unstructured":"Credible meds. Available at: http:\/\/www.crediblemeds.org. Accessed December 26,\u00a02016."},{"key":"10.1016\/j.hrthm.2017.10.036_bib1097","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/CIRCULATIONAHA.111.086983","article-title":"Left ventricular longitudinal function predicts life-threatening ventricular arrhythmia and death in adults with repaired tetralogy of fallot","volume":"125","author":"Diller","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1098","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1161\/01.CIR.92.2.231","article-title":"Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death","volume":"92","author":"Gatzoulis","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1099","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/S0735-1097(97)00316-1","article-title":"Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot","volume":"30","author":"Harrison","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1100","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/hrt.2006.104745","article-title":"Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair","volume":"94","author":"Knauth","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1101","first-page":"401","article-title":"Sudden cardiac death in adult congenital heart disease: can the unpredictable be foreseen?","volume":"19","author":"Koyak","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1102","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1161\/CIRCULATIONAHA.112.104786","article-title":"Sudden cardiac death in adult congenital heart disease","volume":"126","author":"Koyak","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1103","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1510\/icvts.2009.211011","article-title":"Does pulmonary valve replacement post repair of tetralogy of Fallot improve right ventricular function?","volume":"9","author":"Adamson","year":"2009","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1104","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/0002-9149(87)90924-6","article-title":"Electrophysiologic drug testing in symptomatic ventricular arrhythmias after repair of tetralogy of Fallot","volume":"59","author":"Deal","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1105","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/j.hrthm.2014.05.009","article-title":"PACES\/HRS Expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS)","volume":"11","author":"Khairy","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1106","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/CIRCEP.114.001975","article-title":"Ventricular arrhythmia risk stratification in patients with tetralogy of Fallot at the time of pulmonary valve replacement","volume":"8","author":"Sabate Rotes","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1107","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.amjcard.2004.11.037","article-title":"Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair","volume":"95","author":"Therrien","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1108","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1161\/01.CIR.103.20.2489","article-title":"Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot","volume":"103","author":"Therrien","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1109","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/pace.12434","article-title":"Lesion-specific differences for implantable cardioverter defibrillator therapies in adults with congenital heart disease","volume":"37","author":"Kella","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/CIRCEP.111.966754","article-title":"Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?","volume":"5","author":"Koyak","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1111","first-page":"407","article-title":"Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes","volume":"19","author":"Santharam","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1112","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/eurheartj\/ehv735","article-title":"Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis","volume":"37","author":"Vehmeijer","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1113","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1093\/eurheartj\/ehl306","article-title":"Outcome of implantable cardioverter defibrillators in adults with congenital heart disease: a multi-centre study","volume":"28","author":"Yap","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1114","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0002-9149(90)91047-A","article-title":"Ventricular arrhythmias in postoperative tetralogy of Fallot","volume":"65","author":"Chandar","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1115","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1161\/01.CIR.0000126495.11040.BD","article-title":"Value of programmed ventricular stimulation after tetralogy of fallot repair: a multicenter study","volume":"109","author":"Khairy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1116","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCULATIONAHA.107.726372","article-title":"Implantable cardioverter-defibrillators in tetralogy of Fallot","volume":"117","author":"Khairy","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1117","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1161\/CIRCEP.114.001929","article-title":"Re-entry using anatomically determined isthmuses: a curable ventricular tachycardia in repaired congenital heart disease","volume":"8","author":"Kapel","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1118","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1161\/CIRCEP.114.001661","article-title":"Left-sided ablation of ventricular tachycardia in adults with repaired tetralogy of Fallot: a case series","volume":"7","author":"Kapel","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1119","first-page":"268","article-title":"Arrhythmogenic anatomical isthmuses identified by electroanatomical mapping are the substrate for ventricular tachycardia in repaired tetralogy of Fallot","volume":"38","author":"Kapel","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1120","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.hrthm.2016.03.002","article-title":"Mechanism and outcomes of catheter ablation for ventricular tachycardia in adults with repaired congenital heart disease","volume":"13","author":"van Zyl","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1121","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1161\/CIRCULATIONAHA.107.723551","article-title":"Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus","volume":"116","author":"Zeppenfeld","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1122","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/CIRCEP.108.776120","article-title":"Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study","volume":"1","author":"Khairy","year":"2008","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1123","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijcard.2016.02.133","article-title":"Cause of death in adults with congenital heart disease - an analysis of the German National Register for Congenital Heart Defects","volume":"211","author":"Engelings","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1124","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.amjcard.2012.02.057","article-title":"Incidence and predictors of sudden cardiac arrest in adults with congenital heart defects repaired before adult life","volume":"110","author":"Gallego","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1125","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/eurheartj\/eht257","article-title":"Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality","volume":"35","author":"Tutarel","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1126","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0735-1097(91)90586-X","article-title":"Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group","volume":"18","author":"Fish","year":"1991","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1127","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4158\/EP13059.OR","article-title":"Amiodarone-induced thyrotoxicosis in adults with congenital heart disease-clinical presentation and response to therapy","volume":"21","author":"Stan","year":"2014","journal-title":"Endocr Pract"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1128","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.CIR.100.2.149","article-title":"Amiodarone-associated thyroid dysfunction: risk factors in adults with congenital heart disease","volume":"100","author":"Thorne","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1129","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0735-1097(83)80054-0","article-title":"Induction of ventricular tachycardia during electrophysiologic study after repair of tetralogy of Fallot","volume":"1","author":"Garson","year":"1983","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1130","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/CIRCULATIONAHA.109.928481","article-title":"Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study","volume":"122","author":"Khairy","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1131","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.amjcard.2010.04.036","article-title":"Rate of inducible ventricular arrhythmia in adults with congenital heart disease","volume":"106","author":"Tsai","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1132","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/heartjnl-2013-304958","article-title":"Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort","volume":"100","author":"Valente","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1133","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1177\/0218492316667771","article-title":"Fontan circulation over 30 years. What should we learn from those patients?","volume":"24","author":"Sakamoto","year":"2016","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1134","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/CIRCULATIONAHA.108.775221","article-title":"Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia","volume":"119","author":"Harrild","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1135","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.jacc.2008.01.033","article-title":"Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients","volume":"51","author":"Berul","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1136","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.amjcard.2011.04.020","article-title":"Single-center experience with implantable cardioverter-defibrillators in adults with complex congenital heart disease","volume":"108","author":"Khanna","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1137","doi-asserted-by":"crossref","first-page":"e004338","DOI":"10.1161\/CIRCEP.116.004338","article-title":"Clinical experience with the subcutaneous implantable cardioverter-defibrillator in adults with congenital heart disease","volume":"9","author":"Moore","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1138","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1253\/circj.CJ-16-0153","article-title":"Right parasternal lead placement increases eligibility for subcutaneous implantable cardioverter defibrillator therapy in adults with congenital heart disease","volume":"80","author":"Okamura","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1139","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/europace\/eun108","article-title":"Implantable cardioverter-defibrillator therapy in adult patients with tetralogy of Fallot","volume":"10","author":"Witte","year":"2008","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1140","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jacc.2016.05.038","article-title":"Late causes of death after pediatric cardiac surgery: a 60-year population-based study","volume":"68","author":"Raissadati","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1141","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/CIRCULATIONAHA.115.017202","article-title":"Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre","volume":"132","author":"Diller","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1142","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jacc.2007.05.040","article-title":"Causes of late deaths after pediatric cardiac surgery: a population-based study","volume":"50","author":"Nieminen","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1143","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijcard.2010.09.015","article-title":"Circumstances of death in adult congenital heart disease","volume":"154","author":"Zomer","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1144","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.105.606046","article-title":"Presence of a ventricular septal defect and the Mustard operation are risk factors for late mortality after the atrial switch operation: thirty years of follow-up in 417 patients at a single center","volume":"114","author":"Lange","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1145","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0735-1097(00)00864-0","article-title":"Myocardial perfusion and function of the systemic right ventricle in patients after atrial switch procedure for complete transposition: long-term follow-up","volume":"36","author":"Lubiszewska","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1146","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0735-1097(00)00585-4","article-title":"Role of ischemia and infarction in late right ventricular dysfunction after atrial repair of transposition of the great arteries","volume":"35","author":"Millane","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1147","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/eurheartj\/ehp179","article-title":"Ventricular arrhythmias and sudden death in adults after a Mustard operation for transposition of the great arteries","volume":"30","author":"Schwerzmann","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1148","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/europace\/euv297","article-title":"Outcomes following the implantation of cardioverter-defibrillator for primary prevention in transposition of the great arteries after intra-atrial baffle repair: a single-centre experience","volume":"18","author":"Buber","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1149","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/pace.12933","article-title":"Internal cardioverter defibrillator indications and therapies after atrial baffle procedure for d-transposition of the great arteries: a multicenter analysis","volume":"39","author":"Backhoff","year":"2016","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1150","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0002-9149(00)01169-3","article-title":"Mode of death in adults with congenital heart disease","volume":"86","author":"Oechslin","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1151","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/eurheartj\/ehq032","article-title":"Mortality in adult congenital heart disease","volume":"31","author":"Verheugt","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1152","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0735-1097(98)00187-9","article-title":"A\u00a0population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects","volume":"32","author":"Silka","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1153","doi-asserted-by":"crossref","first-page":"8848","DOI":"10.1038\/srep08848","article-title":"NKX2-5 mutations in an inbred consanguineous population: genetic and phenotypic diversity","volume":"5","author":"Abou Hassan","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1154","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ejhg.2015.105","article-title":"A\u00a0systematic variant screening in familial cases of congenital heart defects demonstrates the usefulness of molecular genetics in this field","volume":"24","author":"El Malti","year":"2016","journal-title":"Eur J Human Genet"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1155","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/chd.12317","article-title":"Familial atrial septal defect and sudden cardiac death: identification of a novel NKX2-5 mutation and a review of the literature","volume":"11","author":"Ellesoe","year":"2016","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1156","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1136\/heartjnl-2013-304225","article-title":"The unnatural history of an atrial septal defect: longitudinal 35 year follow up after surgical closure at young age","volume":"99","author":"Cuypers","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1157","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1093\/eurheartj\/ehv097","article-title":"Secundum atrial septal defect is associated with reduced survival in adult men","volume":"36","author":"Kuijpers","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1158","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijcard.2008.06.023","article-title":"Long-term prognosis of congenital heart defects: a systematic review","volume":"131","author":"Verheugt","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1159","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1093\/eurheartj\/ehi396","article-title":"The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease","volume":"26","author":"Engelfriet","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1160","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/chd.12153","article-title":"Arrhythmias and sudden death among older children and young adults following tetralogy of Fallot repair in the current era: are previously reported risk factors still applicable?","volume":"9","author":"Arya","year":"2014","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1161","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.hrthm.2014.11.026","article-title":"Arrhythmic burdens in patients with tetralogy of Fallot: a national database study","volume":"12","author":"Wu","year":"2015","journal-title":"Heart Rhythm"},{"issue":"suppl 8","key":"10.1016\/j.hrthm.2017.10.036_bib1162","first-page":"006","article-title":"Coronary arteries in childhood heart disease: implications for management of young adults","author":"Baraona","year":"2012","journal-title":"J\u00a0Clin Exp Cardiolog"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1163","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1053\/j.semtcvs.2015.08.009","article-title":"Outcomes of truncus arteriosus repair in children: 35 years of experience from a single institution","volume":"28","author":"Naimo","year":"2016","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1164","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/chd.12401","article-title":"Sudden cardiac death and late arrhythmias after the Fontan operation","volume":"12","author":"Pundi","year":"2017","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1165","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa0909545","article-title":"An entirely subcutaneous implantable cardioverter-defibrillator","volume":"363","author":"Bardy","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1166","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","article-title":"Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator","volume":"128","author":"Weiss","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1167","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/eurheartj\/ehu112","article-title":"Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry","volume":"35","author":"Lambiase","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1168","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.jacc.2015.02.047","article-title":"Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and EFFORTLESS registry","volume":"65","author":"Burke","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1169","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/jce.12705","article-title":"Outcome of subcutaneous implantable cardioverter defibrillator implantation in patients with end-stage renal disease on dialysis","volume":"26","author":"El-Chami","year":"2015","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1170","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/heartjnl-2012-303349","article-title":"Suitability for subcutaneous defibrillator implantation: results based on data from routine clinical practice","volume":"99","author":"de Bie","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1171","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.jacc.2012.06.053","article-title":"The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort","volume":"60","author":"Olde Nordkamp","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1172","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.hrthm.2012.09.126","article-title":"Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study","volume":"10","author":"K\u00f6be","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1173","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.hrthm.2014.04.025","article-title":"Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator","volume":"11","author":"Groh","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1174","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/jce.12343","article-title":"Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening","volume":"25","author":"Olde Nordkamp","year":"2014","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1175","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/europace\/eut370","article-title":"How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation?","volume":"16","author":"Randles","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1176","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCEP.108.777888","article-title":"Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005","volume":"1","author":"Al-Khatib","year":"2008","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1177","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ahj.2012.02.012","article-title":"Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy","volume":"163","author":"Olde Nordkamp","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1178","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ccl.2013.11.002","article-title":"The role of the wearable cardioverter defibrillator in clinical practice","volume":"32","author":"Chung","year":"2014","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1179","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jacc.2010.04.016","article-title":"Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival","volume":"56","author":"Chung","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1180","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1540-8159.2009.02590.x","article-title":"Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD)","volume":"33","author":"Klein","year":"2010","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1181","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1161\/CIR.0000000000000394","article-title":"Wearable cardioverter-defibrillator therapy for the prevention of sudden cardiac death: a science advisory from the American Heart Association","volume":"133","author":"Piccini","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1182","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jacep.2016.09.002","article-title":"Benefit of the wearable cardioverter-defibrillator in protecting patients after implantable-cardioverter defibrillator explant. Results from the National Registry","volume":"3","author":"Ellenbogen","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1183","unstructured":"LifeVest Wearable Cardioverter Defibrillator. Available at: http:\/\/www.fda.gov\/MedicalDevices\/ProductsandMedicalProcedures\/DeviceApprovalsandClearances\/Recently-ApprovedDevices\/ucm458494.htm. Accessed August 26,\u00a02016."},{"key":"10.1016\/j.hrthm.2017.10.036_bib1184","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1001\/jama.285.9.1193","article-title":"Improving survival from sudden cardiac arrest: the role of the automated external defibrillator","volume":"285","author":"Marenco","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ehj.2003.12.019","article-title":"ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe","volume":"25","author":"Priori","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1186","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1161\/CIRCULATIONAHA.114.010905","article-title":"Improved survival after out-of-hospital cardiac arrest and use of automated external defibrillators","volume":"130","author":"Blom","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1187","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1111\/j.1540-8167.2002.tb01959.x","article-title":"Automatic external defibrillator: key link in the chain of survival","volume":"13","author":"Koster","year":"2002","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1188","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJM200010263431701","article-title":"Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos","volume":"343","author":"Valenzuela","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1189","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJMoa020932","article-title":"Public use of automated external defibrillators","volume":"347","author":"Caffrey","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1190","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJM200010263431702","article-title":"Use of automated external defibrillators by a U.S. airline","volume":"343","author":"Page","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1191","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1016\/j.jacc.2013.06.048","article-title":"Cardiac arrest at exercise facilities: implications for placement of automated external defibrillators","volume":"62","author":"Page","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1192","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.jacc.2009.11.077","article-title":"Survival after application of automatic external defibrillators before arrival of the emergency medical system: evaluation in the resuscitation outcomes consortium population of 21 million","volume":"55","author":"Weisfeldt","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1193","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1161\/CIRCULATIONAHA.114.008850","article-title":"Temporal trends in coverage of historical cardiac arrests using a volunteer-based network of automated external defibrillators accessible to laypersons and emergency dispatch centers","volume":"130","author":"Hansen","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1194","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1056\/NEJMoa1010663","article-title":"Ventricular tachyarrhythmias after cardiac arrest in public versus at home","volume":"364","author":"Weisfeldt","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1195","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa0801651","article-title":"Home use of automated external defibrillators for sudden cardiac arrest","volume":"358","author":"Bardy","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1196","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1161\/CIR.0000000000000272","article-title":"Part 3: adult basic life support and automated external defibrillation: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations","volume":"132","author":"Travers","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1197","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1540-8167.1993.tb01228.x","article-title":"Bundle branch reentrant ventricular tachycardia: cumulative experience in 48 patients","volume":"4","author":"Blanck","year":"1993","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1198","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1540-8167.2004.03189.x","article-title":"Identification and ablation of three types of ventricular tachycardia involving the his-purkinje system in patients with heart disease","volume":"15","author":"Lopera","year":"2004","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1199","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1111\/j.1540-8159.1995.tb04638.x","article-title":"Long-term clinical outcome of right bundle branch radiofrequency catheter ablation for treatment of bundle branch reentrant ventricular tachycardia","volume":"18","author":"Mehdirad","year":"1995","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1200","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.113.003063","article-title":"Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) study","volume":"129","author":"Dinov","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1201","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1540-8167.2009.01563.x","article-title":"Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-study","volume":"21","author":"Tanner","year":"2010","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1202","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jacc.2015.11.041","article-title":"Long-term success of irrigated radiofrequency catheter ablation of sustained ventricular tachycardia: post-approval THERMOCOOL VT trial","volume":"67","author":"Marchlinski","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1203","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.jacc.2006.07.049","article-title":"Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy","volume":"48","author":"Assomull","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1204","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jacc.2008.11.052","article-title":"Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate","volume":"53","author":"Bogun","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1205","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/0002-9149(87)90618-7","article-title":"Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients","volume":"60","author":"Roberts","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1206","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCEP.113.000537","article-title":"Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy: implications for the ablation strategy","volume":"6","author":"Piers","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1207","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.jacc.2009.10.084","article-title":"Epicardial ventricular tachycardia ablation a multicenter safety study","volume":"55","author":"Sacher","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1208","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/CIRCEP.111.962217","article-title":"Epicardial ablation for ventricular tachycardia: a European multicenter study","volume":"4","author":"Della Bella","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1209","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00428-007-0505-5","article-title":"Guidelines for autopsy investigation of sudden cardiac death","volume":"452","author":"Basso","year":"2008","journal-title":"Virchows Arch"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1210","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/europace\/eut329","article-title":"The importance of specialist cardiac histopathological examination in the investigation of young sudden cardiac deaths","volume":"16","author":"de Noronha","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1211","first-page":"571","article-title":"Genetic testing for inherited cardiac disease. Nature reviews","volume":"10","author":"Wilde","year":"2013","journal-title":"Cardiology"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1212","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.mayocp.2012.02.017","article-title":"Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing","volume":"87","author":"Tester","year":"2012","journal-title":"Mayo Clin. Proc"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carpath.2013.09.002","article-title":"Molecular diagnostics of cardiovascular diseases in sudden unexplained death","volume":"23","author":"Tang","year":"2014","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1214","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.hrthm.2014.01.017","article-title":"Exome analysis-based molecular autopsy in cases of sudden unexplained death in the young","volume":"11","author":"Bagnall","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1215","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa1510687","article-title":"A\u00a0prospective study of sudden cardiac death among children and young adults","volume":"374","author":"Bagnall","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1216","first-page":"359","article-title":"Molecular autopsy in victims of inherited arrhythmias","volume":"32","author":"Semsarian","year":"2016","journal-title":"J\u00a0Arrhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1217","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2459\/JCM.0000000000000234","article-title":"An autopsy study of sudden cardiac death in persons aged 1-40 years in Brescia (Italy)","volume":"17","author":"Vassalini","year":"2016","journal-title":"J\u00a0Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1218","doi-asserted-by":"crossref","first-page":"e2707","DOI":"10.1097\/MD.0000000000002707","article-title":"Forensic pathological study of 1656 cases of sudden cardiac death in southern China","volume":"95","author":"Wu","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1219","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/pace.12479","article-title":"Sudden arrhythmic death syndrome: diagnostic yield of comprehensive clinical evaluation of pediatric first-degree relatives","volume":"37","author":"Giudici","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1220","doi-asserted-by":"crossref","first-page":"e004274","DOI":"10.1161\/CIRCEP.115.004274","article-title":"Cardiac abnormalities in first-degree relatives of unexplained cardiac arrest victims: a report from the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry","volume":"9","author":"Steinberg","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1221","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/CIRCEP.114.001818","article-title":"Cardiac evaluation of pediatric relatives in sudden arrhythmic death syndrome: a 2-center experience","volume":"7","author":"Wong","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1222","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.hrthm.2014.05.028","article-title":"Low rate of cardiac events in first-degree relatives of diagnosis-negative young sudden unexplained death syndrome victims during follow-up","volume":"11","author":"van der Werf","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1223","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/CIRCEP.113.000111","article-title":"Sudden cardiac death with autopsy findings of uncertain significance: potential for erroneous interpretation","volume":"6","author":"Papadakis","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1224","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1225","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1086\/JCE200617109","article-title":"Advance health planning and treatment preferences among recipients of implantable cardioverter defibrillators: an exploratory study","volume":"17","author":"Berger","year":"2006","journal-title":"J\u00a0Clin Ethics"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1226","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40271-014-0055-2","article-title":"Making decisions about implantable cardioverter-defibrillators from implantation to end of life: an integrative review of patients\u2019 perspectives","volume":"7","author":"Lewis","year":"2014","journal-title":"Patient"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1227","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1177\/0269216314550374","article-title":"Patients\u2019 perception of implantable cardioverter defibrillator deactivation at the end of life","volume":"29","author":"Hill","year":"2015","journal-title":"Palliat Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1228","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/jamainternmed.2013.3171","article-title":"Patient perceptions, physician communication, and the implantable cardioverter-defibrillator","volume":"173","author":"Hauptman","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1229","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1540-8159.2011.03237.x","article-title":"Patient and cardiologist perceptions on decision making for implantable cardioverter-defibrillators: a qualitative study","volume":"34","author":"Matlock","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1230","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/jamainternmed.2013.11564","article-title":"Features and outcomes of patients who underwent cardiac device deactivation","volume":"174","author":"Buchhalter","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1231","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/jamainternmed.2013.1883","article-title":"Patient preferences for deactivation of implantable cardioverter-defibrillators","volume":"173","author":"Dodson","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1232","doi-asserted-by":"crossref","first-page":"835","DOI":"10.7326\/0003-4819-141-11-200412070-00006","article-title":"Management of implantable cardioverter defibrillators in end-of-life care","volume":"141","author":"Goldstein","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1233","doi-asserted-by":"crossref","first-page":"296","DOI":"10.7326\/0003-4819-152-5-201003020-00007","article-title":"Brief communication: management of implantable cardioverter-defibrillators in hospice: a nationwide survey","volume":"152","author":"Goldstein","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1234","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.amjcard.2011.08.011","article-title":"Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care","volume":"109","author":"Kirkpatrick","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1235","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.ahj.2008.12.011","article-title":"Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey","volume":"157","author":"Kelley","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1236","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.hrthm.2010.07.018","article-title":"Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment","volume":"7","author":"Kramer","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1237","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1540-8159.2008.01041.x","article-title":"Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes","volume":"31","author":"Mueller","year":"2008","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1238","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40271-014-0055-2","article-title":"Making decisions about implantable cardioverter-defibrillators from implantation to end of life: an integrative review of patients\u2019 perspectives","volume":"7","author":"Lewis","year":"2014","journal-title":"Patient"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1239","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cardfail.2009.09.003","article-title":"Patient expectations from implantable defibrillators to prevent death in heart failure","volume":"16","author":"Stewart","year":"2010","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1240","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/jamainternmed.2013.3171","article-title":"Patient perceptions, physician communication, and the implantable cardioverter-defibrillator","volume":"173","author":"Hauptman","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1241","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/pace.12433","article-title":"\u201cIt\u2019s not broke, so let\u2019s not try to fix it\u201d: why patients decline a cardiovascular implantable electronic device","volume":"37","author":"Ottenberg","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1242","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1540-8159.2012.03497.x","article-title":"Patients\u2019 attitudes and perceptions of implantable cardioverter-defibrillators: potential barriers to appropriate primary prophylaxis","volume":"35","author":"Yuhas","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1243","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/archinte.164.9.977","article-title":"Good and bad dying from the perspective of terminally ill men","volume":"164","author":"Vig","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1244","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0277-9536(96)00221-3","article-title":"Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango)","volume":"44","author":"Charles","year":"1997","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1245","doi-asserted-by":"crossref","first-page":"763","DOI":"10.7326\/0003-4819-125-9-199611010-00010","article-title":"Physician recommendations and patient autonomy: finding a balance between physician power and patient choice","volume":"125","author":"Quill","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1246","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.jacc.2014.03.016","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines","volume":"63","author":"Anderson","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1247","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: Second Panel on Cost-Effectiveness in Health and Medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1248","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1161\/01.CIR.97.21.2129","article-title":"The cost-effectiveness of automatic implantable cardiac defibrillators. Results from MADIT","volume":"97","author":"Mushlin","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1249","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1161\/01.CIR.103.10.1416","article-title":"Cost-effectiveness of the implantable cardioverter-defibrillator. Results from the Canadian Implantable Defibrillator Study (CIDS)","volume":"103","author":"O\u2019Brien","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1250","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1161\/01.CIR.0000015504.57641.D0","article-title":"Cost-effectiveness of the implantable cardioverter-defibrillator versus antiarrhythmic drugs in survivors of serious ventricular tachyarrhythmias. Results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Economic Analysis Substudy","volume":"105","author":"Larson","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1251","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.jacc.2006.03.032","article-title":"The cost-effectiveness of implantable cardioverter-defibrillators. Results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II","volume":"47","author":"Zwanziger","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1252","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/CIRCULATIONAHA.105.581884","article-title":"Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure. Results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)","volume":"114","author":"Mark","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1253","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0002-9343(02)01078-1","article-title":"Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among Medicare beneficiaries","volume":"112","author":"Weiss","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1254","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/0003-4819-142-8-200504190-00007","article-title":"Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II","volume":"142","author":"Al-Khatib","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1255","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta10270","article-title":"A\u00a0review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context","volume":"10","author":"Buxton","year":"2006","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1256","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJMsa051989","article-title":"Cost effectiveness of implantable cardioverter-defibrillators","volume":"353","author":"Sanders","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1257","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/eurheartj\/ehs090","article-title":"The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: A European analysis","volume":"34","author":"Smith","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1258","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/europace\/eup068","article-title":"Lifetime cost-effectiveness of prophylactic implantation of cardioverter defibrillator in patients with reduced left ventricular systolic function: Results of Markov modelling in a European population","volume":"11","author":"Cowie","year":"2008","journal-title":"Europace"},{"issue":"suppl","key":"10.1016\/j.hrthm.2017.10.036_bib1259","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1542-474X.2005.00070.x","article-title":"Cost-effectiveness of implanted defibrillators in young people with inherited cardiac arrhythmias","volume":"10","author":"Goldenberg","year":"2005","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1260","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1056\/NEJM199711273372201","article-title":"Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery","volume":"337","author":"Bigger","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1261","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa041489","article-title":"Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction","volume":"351","author":"Hohnloser","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1262","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1056\/NEJMoa0901889","article-title":"Defibrillator implantation early after myocardial infarction","volume":"361","author":"Steinbeck","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1263","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1053\/euhj.2000.2476","article-title":"Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials","volume":"21","author":"Connolly","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1264","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1067\/mhj.2002.125501","article-title":"Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator","volume":"144","author":"Owens","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1265","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7326\/0003-4819-147-4-200708210-00007","article-title":"Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction","volume":"147","author":"Ezekowitz","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1266","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa0706719","article-title":"Quality of life with defibrillator therapy or amiodarone in heart failure","volume":"359","author":"Mark","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1267","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2165\/11317980-000000000-00000","article-title":"Examination of the effect of implantable cardioverter-defibrillators on health-related quality of life: based on results from the Multicenter Automatic Defibrillator Trial-II","volume":"9","author":"Noyes","year":"2009","journal-title":"American journal of cardiovascular drugs: drugs, devices, and other interventions"},{"key":"10.1016\/j.hrthm.2017.10.036_bib1268","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1001\/archinte.167.20.2226","article-title":"Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study","volume":"167","author":"Passman","year":"2007","journal-title":"Archives of internal medicine"}],"updated-by":[{"DOI":"10.1016\/j.hrthm.2018.09.025","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000}}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154752711731250X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154752711731250X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:52:05Z","timestamp":1761547925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154752711731250X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":1268,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S154752711731250X"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2017.10.036","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2017.10.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American College of Cardiology Foundation, the American Heart Association, Inc., and the Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}